beta-alanine and warfarin

beta-alanine has been researched along with warfarin in 411 studies

Research

Studies (411)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's410 (99.76)24.3611
2020's1 (0.24)2.80

Authors

AuthorsStudies
Díaz-Cremades, JM; Fernández-Fuertes, F; Ruano, JA1
Jamil-Copley, S; Kanagaratnam, P1
Broukhim, M; Halperin, JL1
Freeman, JV; Garber, AM; Go, AS; Hutton, DW; Owens, DK; Turakhia, MP; Wang, PJ; Zhu, RP1
Michota, F1
Oliver, M1
Aikens, TH; Brugada, J; Chernick, M; Connolly, SJ; Ezekowitz, MD; Flaker, G; Kamensky, G; Nagarakanti, R; Oldgren, J; Parekh, A; Reilly, PA; Yang, S; Yusuf, S1
DeDea, L1
Connolly, SJ1
Kirsch, B1
Connolly, SJ; Ezekowitz, MD; Hori, M; Reilly, PA; Wallentin, L; Yusuf, S1
Uchiyama, S2
Beasley, BN; Temple, R; Unger, EF1
Edwards, DB; Silverberg, J1
Berg, AM1
Cannon, CP; Stecker, EC1
Fisher, WD1
Alings, M; Connolly, SJ; Diener, HC; Eikelboom, JW; Ezekowitz, M; Franzosi, MG; Healey, JS; Hohnloser, SH; Huber, K; Kaatz, S; Oldgren, J; Reilly, P; Varrone, J; Wallentin, L; Yang, S; Yusuf, S1
Gage, BF; Shah, SV1
Arnaout, S; Musallam, KM; Rabah, A; Sawaya, FJ; Sawaya, J1
Batjer, HH; Bendok, BR; Bernstein, R; Rahme, RJ1
Lee, TH1
del Zoppo, GJ; Eliasziw, M1
Ganjehei, L; Massumi, A; Rasekh, A; Razavi, M1
Arya, R; Patel, JP; Roberts, LN1
Mega, JL1
Averkov, OV1
Di Pasquale, G; Riva, L1
Hunchuck, JE; Lake, JD1
Crippa, L; Falanga, A; Finazzi, G; Manotti, C; Marongiu, F; Palareti, G; Pengo, V; Poli, D; Testa, S; Tiraferri, E; Tosetto, A; Tripodi, A1
Engel, G; Kong, MH; Mead, RH; Patrawala, RA; Winkle, RA3
Diener, HC; Eikelboom, JW; Hohnloser, SH; Weimar, C1
Bartholomew, JR; Wartak, SA1
Acharjee, S; Cannon, CP1
Jolobe, OM1
Yates, SW1
Alings, M; Connolly, SJ; Darius, H; Diener, HC; Eikelboom, J; Ezekowitz, MD; Kamensky, G; Oldgren, J; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S1
Beyth, RJ; Landefeld, CS1
Al-Khatib, SM; Alexander, JH; Granger, CB; Lopes, RD; Mahaffey, KW; Patel, MR1
Panchenko, EP1
Smith, V1
Diener, HC; Hohnloser, SH; Lip, GY; Weber, R1
Deloughery, TG; Liem, TK2
Büller, HR; Combe, S1
Asakura, H1
Banerjee, A; Lane, DA; Lip, GY; Torp-Pedersen, C1
Brueckmann, M; Connolly, SJ; Eikelboom, J; Ezekowitz, M; Hohnloser, SH; Oldgren, J; Reilly, P; Wallentin, L; Yang, S; Yusuf, S1
Freuler, M; Pezzotti, W1
Abu-Fadel, MS; Dib, C; Golwala, H; Tafur, A1
Diener, HC; Eikelboom, J; Granger, CB; Hacke, W1
Govindarajan, R; Salgado, E1
Parra, D; Reynolds, S; Rosenstein, RS1
Reiffel, JA1
Parma, Z; Syzdół, M; Tendera, M1
Knight, BP1
Burkhardt, JD; Chalhoub, F; Coffey, J; D'Avila, A; Di Biase, L; Lakkireddy, D; Mansour, MC; Mohanty, P; Monir, G; Natale, A; Pimentel, R; Reddy, VY; Reddy, YM; Ruskin, J; Sanchez, JE; Santangeli, P; Shaik, N; Swarup, V; Vanga, SR1
Easton, JD; Johnston, SC; Kamel, H; Kim, AS1
Abraham, ME; Marcy, TR1
Alpert, JS1
Brueckmann, M; Connolly, S; Ezekowitz, M; Flaker, G; Hohnloser, SH; Noack, H; Reilly, P; Wallentin, L; Yusuf, S1
Adcock, AK; Aguilar, MI; Demaerschalk, BM; Hoffman-Snyder, CR; Lee-Iannotti, JK; Wellik, KE; Wingerchuk, DM1
Abdelhafiz, AH; Ali, A; Bailey, C1
Pazmiño, PA1
Khemasuwan, D; Suramaethakul, N1
DiNicolantonio, JJ1
Bryer, A1
Baumgarten, P; Bohmann, F; Foerch, C; Lindhoff-Last, E; Mittelbronn, M; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H1
Amin, A; Deitelzweig, S; Graham, J; Jing, Y; Lin, J; Makenbaeva, D; Wiederkehr, D2
Connolly, SJ; Diener, HC; Ezekowitz, MD; Hart, RG; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S1
Baker, RI; Harper, P; McLintock, C1
Chatelain, B; Chatelain, C; Dogné, JM; Douxfils, J; Mullier, F; Spinewine, A; Sternotte, A1
Eisenberg, MJ; Filion, KB; Grandi, SM; Miller, CS; Shimony, A1
Bianco, RW; Lahti, MT; Medina, EM; Schomburg, JL1
Mustonen, P; Puurunen, M1
Halperin, JL; Varughese, CJ1
Schulman, S4
Aguilar, MI; Freeman, WD; Kuo, R1
Vanerio, G; Vidal, A1
Firriolo, FJ; Hupp, WS1
Das, P; Jha, SK; Kabra, R; Koshy, SK; Shaheen, MH1
Licina, MM; Lip, GY; Polovina, MM; Potpara, TS; Prostran, MS; Stojanovic, RM1
Freeman, MK; Hughes, PJ1
Avezum, A; Connolly, SJ; Douketis, J; Eikelboom, J; Ezekowitz, M; Healey, JS; Heidbuchel, H; Heidbuchle, H; Oldgren, J; Reilly, P; Themeles, E; Wallentin, L; Yang, S; Yusuf, S1
Garcia, DA; Granger, CB1
Bhatt, DL; Kar, S1
Ataullakhanov, FI; Panteleev, MA; Sinauridze, EI1
Davidson, T; Husberg, M; Janzon, M; Levin, LÅ; Oldgren, J1
Callahan, S; Goldsberry, A; Kim, G; Yoo, S1
Ansell, J; Mantha, S1
Cheng, G; Tsui, KK; Wong, RS; You, JH1
Radecki, RP1
Finsterer, J; Stöllberger, C2
Agnifili, M; Bedogni, F; Brambilla, N; De Marco, F; Lanotte, S; Latib, A; Latini, RA; Laudisa, ML; Mattioli, R; Oreglia, J; Pizzocri, S; Testa, L1
Fuke, E; Hayano, M; Kaseno, K; Kumagai, K; Miki, Y; Naito, S; Nakamura, K; Nishiuchi, S; Oshima, S; Sakamoto, T; Sasaki, T; Tada, H; Tsukada, N; Yamashita, E1
Avorn, J; Choudhry, NK; Gagne, JJ; Patrick, AR; Schneeweiss, S1
Reed, SD1
Bilen, O; Teruya, J1
Crippa, L; Falanga, A; Finazzi, G; Manotti, C; Marongiu, F; Moia, M; Palareti, G; Pengo, V; Poli, D; Siragusa, S; Testa, S; Tiraferri, E; Tosetto, A; Tripodi, A1
Huang, C; Shin, J; Siu, M; Vu, L; Wong, S1
Kanorskiĭ, SG; Shevelev, VI1
Zhang, S1
Al-Sallami, HS; Duffull, SB; Faed, JM; Wright, DF; Zufferey, PJ1
Destephan, C; Dhruvakumar, S; Gerula, C; Kaluski, E; Maher, J; Mazza, V; Patel, RJ; Waller, AH1
Johns, G; Kauffman, C; Kusumoto, F; Prussak, K; Snipelisky, D; Venkatachalam, K1
Griffiths, M; Scully, C1
Taylor, J1
Jin, M; Kamrul, R; Kosar, L; Schuster, B1
Bradley-Kennedy, C; Clemens, A; Kansal, AR; Monz, BU; Peng, S; Roskell, N; Sharma, M; Sorensen, SV1
Nguyen, T; Wong, E1
Alonso-Coello, P; Guyatt, G; Zhou, Q1
Ahmad, Y; Lip, GY2
Alexander, GC; Kirley, K; Kornfield, R; Qato, DM; Stafford, RS1
Álvarez-Sabin, J; Becerra, V; González-Juanatey, JR; González-Rojas, N; Lobos, JM; Martínez-Rubio, A; Oyagüez, I; Reverter, JC1
Haas, S; Kreutz, R; Llau, J; Norrving, B; Turpie, AG1
Cheema, AA; Jones, P; Konduru, SV; Li, Y; Ramza, B; Wimmer, AP1
Fadda, V; Maratea, D; Messori, A; Trippoli, S1
Gonzalez, MD; Naccarelli, GV1
Koziński, M; Kubica, A; Kubica, J; Navarese, EP; Obońska, K1
McBane, RD; Tafur, A; Wysokinski, WE1
Merli, GJ1
Aalbers, J1
Chang, AM; Ho, JC; Lam, YY; Lee, VW; Yan, BP; Yu, CM2
Valle Bernad, R1
Blanco-Molina, A1
Hirayama, H; Inden, Y; Kamiya, H; Murohara, T; Nanasato, M; Nin, T; Sairaku, A; Tatematsu, Y; Yoshida, Y1
Okada, Y; Yasaka, M2
Wooten, JM1
Martin, EN; Money, SR; Shamoun, FE1
Gross, PL; Weitz, JI1
Bogun, F; Carrigan, T; Chugh, A; Crawford, T; Ghanbari, H; Good, E; Jongnarangsin, K; Kennedy, R; Kim, JS; Latchamsetty, R; Morady, F; Oral, H; Pelosi, F; Saint-Phard, W; She, F; Sinno, M; Suwanagool, A; Yokokawa, M1
Connolly, SJ; Coppens, M; Dale, B; Eikelboom, JW; Ginsberg, JS; Hirsh, J; Paikin, JS; Weitz, JI; Whitlock, RP; Young, E1
Kanorsky, SG; Shevelev, VI1
Deitelzweig, SB1
Greenspon, AJ1
Brem, E; Foran, M; Koyfman, A1
Douketis, JD; Faraoni, D; Levy, JH; Samama, CM; Spring, JL1
Dyrkorn, R; Roland, PD1
Baanstra, D; Eriksson, H; Friedman, J; Goldhaber, SZ; Kakkar, AK; Kearon, C; Kvamme, AM; Mismetti, P; Schellong, S; Schulman, S1
Connors, JM1
Agewall, S; Andreotti, F; Atar, D; Cattaneo, M; Collet, JP; Grove, EL; Huber, K; Husted, S; Kjeldsen, K; Lip, GY; Morais, J; Pathak, A; Rosano, G; Storey, RF; Verheugt, FW; Wassmann, S1
Devlin, HL; Hosman, AE; Shovlin, CL1
Berman, JP; Halperin, JL1
Lenchus, JD1
Apostolakis, S; Kasmeridis, C; Lip, GY1
Dolgin, E1
Reichman, ME; Southworth, MR; Unger, EF1
Albaladejo, P; David, JS; Piriou, V1
Hjemdahl, P; Johnsson, H; Wallén, NH1
Camarero, MO; Castaño, MP; Milla, SL; Piñero-Saavedra, M1
Berger, R; Chase, M; Ganetsky, M; Salhanick, SD1
Bergh, M; Marais, CA; Miller-Jansön, H; Salie, F; Stander, MP1
Armstrong, EP; Harrington, AR; Malone, DC; Nolan, PE1
Abi-Saleh, B; Alam, S; Baranowski, B; Bassiouny, M; Borek, PP; Callahan, T; Chung, M; Diab, M; Dresing, T; Hussein, A; Kanj, M; Khoury, M; Lindsay, BD; Martin, DO; Niebauer, M; Rickard, J; Saliba, W; Sengupta, J; Sey, A; Shao, M; Tchou, PJ; Varma, N; Wazni, O2
Doppalapudi, H; Gunter, A; Kay, GN; Maddox, W; McElderry, HT; Osorio, J; Plumb, VJ; Yamada, T1
Attia, JR; Pearce, R1
Eikelboom, JW; Hankey, GJ1
Jeffery, SM; Ogbonna, KC1
Badimón, JJ; Briongos Figuero, S; García Santos-Gallego, C1
Limdi, NA; Thigpen, JL1
Chevalier, J; de Pouvourville, G; Giroud, M1
Ploen, R; Sun, L; Veltkamp, R; Zhou, W; Zorn, M1
Bradley-Kennedy, C; Kansal, AR; Monz, BU; Peng, S; Sorensen, SV1
Hughes, DA; Pink, J; Pirmohamed, M1
Asmussen, MB; Hesselbjerg, LJ; Pedersen, HS; Petersen, KD1
Ellis, CR; Kaiser, DW; Nagarakanti, R; Streur, MM; Whalen, SP1
Yasaka, M1
Avila, C; Gullett, D; Johnson, ES; Kokaram, CR; Parra, MW; Wichner, ZA; Zucker, L1
Kalus, JS1
Avezum, A; Connolly, SJ; Douketis, J; Eikelboom, J; Ezekowitz, M; Healey, JS; Heidbuchel, H; Oldgren, J; Reilly, P; Themeles, E; Wallentin, L; Yang, S; Yusuf, S1
Atay, JK; Barnes, GD; Coatney, J; Ehle, M; Fanikos, J; Froehlich, JB; Goldhaber, SZ; Piazza, G1
Pelargonio, G; Perna, F1
Spyropoulos, AC; Turpie, AG1
Connolly, SJ; Korhonen, M; Monz, BU; Noack, H; Pooley, J1
Bett, N; Hamilton-Craig, C; Luis, C; Luis, SA; Poon, K; Shukla, A1
Micieli, A; Singh, SM; Wijeysundera, HC1
Heidenreich, PA1
Aisenberg, J; Desai, J; Kolb, JM; Weitz, JI1
Bauer, KA1
Klein, HH1
Amnueypol, M; Calkins, H; Haines, DE; Marchlinski, FE; Mead-Salley, M; Nademanee, K; Saklani, P; Salazar, M; Skanes, AC; Yarmohammadi, H; Zado, E1
Bovio, JA; Franck, AJ1
Hegerfeldt, Y1
Edwards, JL1
Connolly, SJ; Eikelboom, JW; Hart, RG; Oldgren, J; Reilly, P; Wallentin, L; Yang, S; Yusuf, S1
Pollack, CV1
Gong, IY; Kim, RB1
Cameron, C; Coyle, D; Coyle, K; Kelly, S; Lee, K; Steiner, S; Wells, GA1
Boos, CJ; Camm, AJ; Nam, M1
Diener, HC1
Bates, P; Culpan, P; El-Daly, I; Reidy, J1
Lopes, RD; Newby, LK; Truffa, AA1
Brueckmann, M; Connolly, SJ; Ezekowitz, MD; Ferreira, J; Fraessdorf, M; Reilly, PA; Wallentin, L; Yusuf, S1
Bhimani, AA; Hong, M1
Kamal, AK; Kamran, SH; Muzammil, SM1
Al-Majzoub, O; Assiri, A; Donovan, JL; Kanaan, AO; Silva, M1
Bamimore, A; Mounsey, JP1
Djalali, S1
Albenque, JP; Bouzeman, A; Boveda, S; Casteigt, B; Combes, N; Combes, S; Marijon, E; Narayanan, K; Providência, R1
Doppalapudi, H; Gunter, A; Jennings, JM; Kay, GN; McElderry, HT; Osorio, J; Plumb, VJ; Robichaux, R; Yamada, T1
Daoud, EG; Kahwash, R1
Fauchier, L; Gruel, Y; May, MA1
Dalen, JE1
DeRemer, CE; Elewa, HF; Gujral, J; Joshua, TV; Keller, K1
Bell, S; Dawes, M; Nand, J1
Fanikos, J1
Dinkel, J; Foerch, C; Gupta, R; Hayakawa, K; Karatas, H; Lauer, A; Leung, W; Lo, EH; Schlunk, F; Steinmetz, H; Won, SY1
Davis, C; Lee, M; Robertson, C; Shivakumar, S1
Alvrtsyan, H; Francis, K; Matchar, D; Miyasato, G; Rao, Y; Sanchez, H; Sander, S; Siu, K; Walker, D; Yu, C; Zalesak, M1
Avorn, J1
Hamasaki, S; Ichiki, H; Iriki, Y; Ishida, S; Maenosono, R; Miyata, M; Namino, F; Ninomiya, Y; Oketani, N; Okui, H; Tei, C1
Ansell, J; Shameem, R1
Diener, HC; Easton, JD; Hankey, GJ; Hart, RG1
Agnelli, G; Becattini, C; Franco, L1
den Exter, PL; Huisman, MV; Kooiman, J; van der Hulle, T1
Eriksson, BI; Quinlan, DJ1
Cohen, AA; Rider, T1
Lip, GY; Van Gelder, IC; Van Veldhuisen, DJ1
Doraiswamy, VA; Gesheff, MG; Gurbel, PA; Slepian, MJ; Tantry, US1
Rosenfeld, JV; Schaerf, NB; Thomas, PA1
Hylek, EM1
Blatchford, J; Brueckmann, M; Connolly, SJ; Devenny, K; Eikelboom, JW; Friedman, J; Granger, CB; Guiver, K; Harper, R; Kappetein, AP; Khder, Y; Lobmeyer, MT; Maas, H; Mack, MJ; Simoons, ML; Van de Werf, F; Voigt, JU1
Crystal, E; Danon, A; Healey, JS; Kansal, N; Lashevsky, I; Morillo, CA; Newman, D; Schulman, S; Shurrab, M1
Brodsky, SV; Hebert, L; Nadasdy, G; Nadasdy, T; Qamri, Z; Rovin, B; Ryan, M; Satoskar, A; Ware, K; Wu, H1
Brueckmann, M; Connolly, S; Eikelboom, J; Ezekowitz, M; Le Heuzey, JY; Marijon, E; Pogue, J; Themeles, E; Wallentin, L; Yang, S; Yusuf, S2
Brunkhorst, R; Foerch, C; Lindhoff-Last, E; Luger, S; Pfeilschifter, W1
Roberts, A1
Azuma, S; Lum, CJ1
Holmes, D1
Hughes, DA; Lane, S; Pink, J; Pirmohamed, M1
Artang, R; Nielsen, JD; Rome, E; Vidaillet, HJ1
Brueckmann, M; Connolly, SJ; Eikelboom, JW; Ezekowitz, MD; Fraessdorf, M; Hwang, HG; Majeed, A; Schulman, S; Wallentin, L; Yusuf, S2
Paré, G; Ross, S1
Kornej, J; Lip, GY; Potpara, T1
Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V1
Chandler, WL1
Bin Abdulhak, AA; Khan, AR; Tleyjeh, IM; Wimmer, AP1
Liberato, NL; Marchetti, M; Quaglini, S; Rognoni, C1
Cove, CL; Hylek, EM1
Curnew, G; Holbrook, A; Hong, C; Kim, S; Pullenayegum, E; Schulman, S1
Avorn, J; Brennan, TA; Canestaro, WJ; Choudhry, NK; Ito, K; Matlin, OS; Patrick, AR; Shrank, WH1
Celik, S; Sipahi, I; Tozun, N1
Abe, K; Deguchi, K; Ikeda, Y; Kono, S; Kurata, T; Omote, Y; Yamashita, T; Yunoki, T1
Manning, JA1
Kitazono, T1
Laffan, M; Shapiro, S1
Andersson, U; Connolly, SJ; Eikelboom, JW; Ezekowitz, MD; Hijazi, Z; Hohnloser, SH; Oldgren, J; Reilly, PA; Siegbahn, A; Wallentin, L; Yusuf, S2
Clemens, A; Connolly, SJ; Ferreira, J; Lip, GY; Noack, H; Yusuf, S1
Albenque, JP; Boveda, S; Marijon, E; Providência, R1
Kolias, TJ1
Bounameaux, H; Verhamme, P1
Christiansen, AV; Eriksson, H; Friedman, J; Goldhaber, SZ; Kakkar, AK; Kearon, C; Le Maulf, F; Mismetti, P; Peter, N; Schellong, S; Schulman, S1
Pai, RG; Tafreshi, J; Zough, F1
Gorst-Rasmussen, A; Lane, DA; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F2
Christensen, TD; Larsen, TB1
Brueckmann, M; Eikelboom, JW; van de Werf, F2
Battista, M; Guglielmetti, G; Stratta, P1
Sharma, S; Singh, S1
Deakin, A; Speirs, A1
Begg, EJ; Chin, PK; Wright, DF1
Biocina, B; Gasparovic, H; Petricevic, M1
Bajorek, B; Wang, Y1
Stewart, RA1
Gupta, K; Singh, D; Vacek, JL1
Giugliano, RP; Gonzalez-Quesada, CJ1
Gorst-Rasmussen, A; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F1
Foerch, C; Lauer, A; Leung, W; Lo, EH; Lok, J; Schaefer, JH; Van Cott, EM; van Leyen, K; van Ryn, J; Whalen, M; Wu, L1
Crowther, M; Pasierski, T; Undas, A; Windyga, J1
Badhwar, N; Gerstenfeld, EP; Lee, BK; Lee, RJ; Marcus, GM; Olgin, J; Scheinman, M; Stepanyan, G; Tseng, ZH; Vedantham, V1
Bress, A; McConeghy, KW; Nutescu, EA; Qato, DM; Wing, C1
Cordova, EG; del Aguila, D; Salazar, CA1
Thachil, J1
Hagen, G; Klemp, M; Wisløff, T1
Piccini, JP; Steinberg, BA1
Ibrahim, S; Jespersen, J; Poller, L1
Davidson, N; Galloway, SW; Lai, A; Thachil, J1
Brannath, W; Schmidt, S1
Brieger, D1
Cotté, FE; Durand-Zaleski, I; Gaudin, AF; Kachaner, I; Kongnakorn, T; Lanitis, T1
Cohen, AT; Granziera, S1
Birnie, DH; Essebag, V; Healey, JS1
Avorn, J; Brennan, TA; Brill, G; Choudhry, NK; Desai, NR; Krumme, AA; Matlin, OS; Pezalla, EJ; Schneeweiss, S; Shrank, WH; Spettell, CM1
Hürlimann, D; Noll, G; Noll, S1
Breik, O; Cheng, A; Goss, A; Sambrook, P1
Fernández de Velasco Pérez, D1
Hess, T; Konturek, P1
Baker, WL; Chamberlin, KW1
Angeli, F; Lip, GY; Reboldi, G; Verdecchia, P1
Alonso, A; Bengtson, LG; Chen, LY; Lakshminarayan, K; Lutsey, PL; MacLehose, RF1
Aryal, MR; Bhandari, Y; Donato, A; Jalota, L; Karmacharya, P; Mainali, NR; Pandit, A; Pathak, R; Pradhan, R; Ukaigwe, A1
Askonen, K; Halinen, M; Huikuri, H; Koistinen, J; Parikka, H; Puurunen, M; Raatikainen, P; Virtanen, V1
Brodsky, SV; Hebert, LA; Ivanov, I; Muni, N; Nadasdy, G; Nadasdy, T; Rovin, BH; Satoskar, AA; Vance, JC; Ware, KM1
AbuDagga, A; Fu, AC; Kwong, WJ; Stephenson, JJ; Tan, H; Weintraub, WS1
Cohen, MR; Mattison, DR; Moore, TJ1
McCormick, NJ; Meechan, JG; Moore, UJ; Norouzi, M1
Bongu, NR; Kocheril, AG; Turagam, MK; Velagapudi, P1
Chrischilles, E; Cram, P; Jones, M; Mazur, A; Vaughan Sarrazin, MS1
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE1
Punjabi, PP; Sarvananthan, S1
Amin, A; Lawrence, JH; Makenbaeva, D; Stokes, M; Wiederkehr, D; Wu, N1
Bang, OY; Chung, CS; Kim, GM; Kim, JS; Kim, SJ; Lee, KH; Lee, MJ; Park, YK; Ryoo, S; Yoon, CH1
Beurtheret, S; Seitz, J1
Brueckmann, M; Clemens, A; Konstantinides, S; Lip, GY; Noack, H; Strack, A1
Rudakova, AV; Tatarskiĭ, BA1
Carroll, VS; Frei, J1
Gorst-Rasmussen, A; Lane, DA; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F1
Hifumi, T; Kiriu, N; Takada, H1
Bennell, MC; Krahn, M; Micieli, A; Pham, B; Singh, SM; Wijeysundera, HC1
Fosbøl, EL; Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C; Weeke, P1
Connolly, SJ; Wallentin, L; Yusuf, S1
Bollmann, A; Breithardt, OA; Darma, A; Dinov, B; Doering, M; Hindricks, G; Kosiuk, J; Koutalas, E; Nedios, S; Richter, S; Rolf, S; Sommer, P1
Giugliano, RP; Plitt, A1
Barnes, GD; Eagle, KA; Froehlich, JB1
Madhusudhana, S; Qasem, A; Strasser, KM1
Ammollo, CT; Colucci, M; Semeraro, N; Testa, S; Visino, F; Zaccaria, F1
Kadauke, S; Khor, B; Van Cott, EM1
Kovács, T1
Shah, R1
Ko, Y; Kong, MC; Lee, LH; Ng, HJ; Wang, Y; Xie, F1
de Boer, A; Hasrat, F; Maitland-van der Zee, AH; Redekop, WK; Verhoef, TI1
Ezekowitz, MD; Kent, AP1
Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR1
Goulding, MR; Graham, DJ; Houstoun, M; Kelman, JA; Levenson, M; MaCurdy, TE; Mott, K; Reichman, ME; Sheu, TC; Southworth, MR; Wernecke, M; Worrall, C; Zhang, R1
Redberg, RF1
Baik, SH; Hernandez, I; Piñera, A; Zhang, Y1
Duart, M; Kauffman, C; Kusumoto, F; Ray, JC; Snipelisky, D; Ung, R1
Bell, AD; Douketis, J; Eikelboom, J; Liew, A1
Eikelboom, JW; Hart, RG1
Chan, KH; Chan, PH; Cheung, E; Hai, JJ; Ho, CW; Ho, MH; Lau, CP; Lau, KK; Leung, GK; Lip, GY; Siu, CW; Tse, HF; Yeung, CY1
Chin, PK; Florkowski, CM; Wright, DF1
Carney, EF1
Cairns, JA; Weitz, JI1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM1
Armbruster, HL; Berger, RD; Calkins, H; Habibi, M; Khurram, IM; Lindsley, JP; Marine, JE; Moranville, MP; Spragg, DD1
Belikov, LN; Savchuk, OF; Sukovatykh, BS; Sukovatykh, MB1
Forslund, T; Hjemdahl, P; Holmström, M; Johnsson, H; von Euler, M; Wettermark, B1
Arepally, GM; Ortel, TL1
Chan, KE; Edelman, ER; Maddux, FW; Thadhani, RI; Wenger, JB1
Rockey, DC1
Einecke, D1
Cantürk, E; Güler, E; Karaca, O; Kızılırmak, F; Omaygenç, O1
Hasler, S1
Feng, X; Huan, Y; Lv, Y1
Chan, PH; Hai, JJ; Siu, CW1
Crighton, A; Gibson, J; Scott, A1
Bultas, J1
Beauchesne, M; Blais, L; Brais, C; Farand, P; Larochelle, J; Letemplier, G; Perreault, S; Tousignant, A; Turgeon, M1
Angaran, P; Bell, AD; Berall, M; Bucci, C; Demchuk, AM; Essebag, V; Goldin, L; Goodman, SG; Green, MS; Gregoire, JC; Gross, PL; Heilbron, B; Lin, PJ; Patel, AD; Ramanathan, K; Skanes, A; Tan, MK; Wheeler, BH1
Oberhofer, E1
Hogg, K; Weitz, JI; Yeh, CH1
Bosch, J; Eikelboom, JW1
Mracsko, E; Na, SY; van Ryn, J; Veltkamp, R1
Abraham, NS; Alexander, GC; Crown, W; Haas, LR; Heien, H; Shah, ND; Singh, S1
Alexander, GC; Chang, HY; Singh, S; Tang, W; Zhou, M1
Rose, A; Vaughan Sarrazin, MS1
Gehrie, E; Tormey, C1
Phillips, R1
Fujita, M; Hirai, M; Inden, Y; Ishikawa, S; Kato, H; Miyoshi, A; Murohara, T; Nagao, T; Ohguchi, S; Okumura, S; Shimano, M; Yamamoto, T; Yanagisawa, S; Yoshida, N1
Lythgoe, M1
Lewis, LS1
Miyares, MA1
Brewster, LM; Horjus, DL; van Montfrans, GA1
Azoulay, L; Klil-Drori, A1
Kreuzer, J; Zint, K1
Kim, CO; Liu, S; Lucyk, SN1
Damkier, P; Hansen, MR; Henriksen, DP1
Hernandez, I; Zhang, Y1
Koretz, RL1
Lavine, JB1
Potpara, TS1
McBane, RD; Schaefer, JK; Wysokinski, WE1
Torjesen, I1
Alonso, A; Bengtson, LGS; Chen, LY; Lutsey, PL; MacLehose, RF1
Ummarino, D1
Sugiyama, T1
Chan, EW; Lau, WCY; Wong, ICK1
Calkins, H; Nordaby, M1
Seligman, SJ1
Larsen, JM; Løfgren, B; Pareek, M1
Dobrev, D; Fender, AC1
Aggarwal, R; Aghoram, R; Kar, SS; Kumar, SM; Rajasulochana, SR1

Reviews

125 review(s) available for beta-alanine and warfarin

ArticleYear
Stroke in atrial fibrillation--hope on the horizon?
    Journal of the Royal Society, Interface, 2010, Dec-06, Volume: 7 Suppl 6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Heart Atria; Humans; Prostheses and Implants; Stroke; Warfarin

2010
Stroke prevention in the high-risk atrial fibrillation patient: Medical management.
    Current cardiology reports, 2011, Volume: 13, Issue:1

    Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Health Status Indicators; Humans; Risk Assessment; Stroke; Vitamin K; Warfarin

2011
Intracerebral hemorrhage: Pick your poison.
    Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:11

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chronic Disease; Dabigatran; Humans; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Venous Thromboembolism; Warfarin

2010
Atrial fibrillation in 2010: advances in treatment and management.
    Nature reviews. Cardiology, 2011, Volume: 8, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin

2011
[Dabigatran, a new oral anticoagulant].
    Brain and nerve = Shinkei kenkyu no shinpo, 2011, Volume: 63, Issue:4

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin

2011
New options for stroke prevention in atrial fibrillation.
    The American journal of managed care, 2010, Volume: 16, Issue:10 Suppl

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin

2010
New oral anticoagulants and outpatient prophylaxis of venous thromboembolism.
    The American journal of managed care, 2011, Volume: 17, Issue:1 Suppl

    Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Guideline Adherence; Heparin, Low-Molecular-Weight; Humans; Morpholines; Outpatients; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Time Factors; Venous Thromboembolism; Warfarin

2011
Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation?
    Neurosurgery, 2011, Volume: 68, Issue:2

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Stroke; Warfarin

2011
Stroke prevention in nonvalvular atrial fibrillation.
    Texas Heart Institute journal, 2011, Volume: 38, Issue:4

    Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiac Catheterization; Cardiac Surgical Procedures; Dabigatran; Humans; Preventive Health Services; Stroke; Treatment Outcome; Warfarin

2011
Anticoagulating obese patients in the modern era.
    British journal of haematology, 2011, Volume: 155, Issue:2

    Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Humans; Morpholines; Multicenter Studies as Topic; Obesity; Polysaccharides; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Venous Thrombosis; Warfarin

2011
[Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].
    Kardiologiia, 2011, Volume: 51, Issue:7

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Echocardiography, Three-Dimensional; Electric Countershock; Humans; International Normalized Ratio; Premedication; Randomized Controlled Trials as Topic; Risk Adjustment; Thromboembolism; Time Factors; Warfarin

2011
[Thromboembolic prophylaxis 2011: is warfarin on the wane?].
    Giornale italiano di cardiologia (2006), 2011, Volume: 12, Issue:9

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Evidence-Based Medicine; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin

2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).
    Thrombosis and haemostasis, 2011, Volume: 106, Issue:5

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Substitution; Evidence-Based Medicine; Hemorrhage; Humans; Italy; Patient Selection; Primary Prevention; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin

2011
Preventing cardioembolic stroke in atrial fibrillation with dabigatran.
    Current neurology and neuroscience reports, 2012, Volume: 12, Issue:1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Embolism; Hemorrhage; Humans; Myocardial Infarction; Stroke; Warfarin

2012
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism.
    Critical pathways in cardiology, 2011, Volume: 10, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biopharmaceutics; Blood Coagulation; Clinical Trials, Phase III as Topic; Dabigatran; Drug Approval; Drug Dosage Calculations; Drug Monitoring; Humans; Risk Assessment; Therapeutic Equivalency; Thrombin; Thromboembolism; Warfarin

2011
Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Hospital practice (1995), 2011, Volume: 39, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Humans; Pyrazoles; Pyridones; Risk Factors; Stroke; Warfarin

2011
Promise of factor Xa inhibition in atrial fibrillation.
    Current cardiology reports, 2012, Volume: 14, Issue:1

    Topics: Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Randomized Controlled Trials as Topic; Risk Factors; Stroke; United States; Warfarin

2012
[Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].
    Kardiologiia, 2011, Volume: 51, Issue:11

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Hemodynamics; Hemorrhage; Humans; Risk Factors; Stroke; Therapeutic Equivalency; Treatment Outcome; Ventricular Dysfunction, Left; Warfarin

2011
Stroke prevention in atrial fibrillation: do we still need warfarin?
    Current opinion in neurology, 2012, Volume: 25, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Decision Making; Factor Xa Inhibitors; Humans; Risk Factors; Stroke; Thrombin; Vitamin K; Warfarin

2012
Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.
    Seminars in vascular surgery, 2011, Volume: 24, Issue:3

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Randomized Controlled Trials as Topic; Venous Thromboembolism; Warfarin

2011
[Interpretation of hemostatic and fibrinolytic markers].
    Rinsho byori. The Japanese journal of clinical pathology, 2011, Volume: 59, Issue:10

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Partial Thromboplastin Time; Plasminogen Activators; Prothrombin Time; Thrombomodulin; Warfarin

2011
Using anticoagulants to steer clear of clots.
    Nursing, 2012, Volume: 42, Issue:2

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Heparin; Humans; Thrombosis; Warfarin

2012
A new era of antithrombotic therapy in patients with atrial fibrillation.
    The American journal of the medical sciences, 2012, Volume: 344, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation?
    Cardiology journal, 2012, Volume: 19, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Evidence-Based Medicine; Hemorrhage; Humans; Morpholines; Patient Selection; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Time Factors; Treatment Outcome; Warfarin

2012
Warfarin versus dabigatran: comparing the old with the new.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012, Volume: 27, Issue:2

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Warfarin

2012
Is dabigatran cost effective compared with warfarin for stroke prevention in atrial fibrillation? A critically appraised topic.
    The neurologist, 2012, Volume: 18, Issue:2

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Humans; Male; Stroke; Warfarin

2012
Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2012, Volume: 18, Issue:5

    Topics: Acute Coronary Syndrome; Administration, Oral; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Vitamin K; Warfarin

2012
Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire international, 2012, Volume: 21, Issue:124

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; International Normalized Ratio; Liver; Myocardial Infarction; Warfarin

2012
Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.
    Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; Stroke; Warfarin

2012
[Clinical studies, the interests and limits of using dabigatran in atrial fibrillation].
    Journal de pharmacie de Belgique, 2012, Issue:1

    Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Antidotes; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Female; Humans; Male; Monitoring, Physiologic; Platelet Aggregation; Stroke; Thromboembolism; Warfarin

2012
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
    The American journal of cardiology, 2012, Aug-01, Volume: 110, Issue:3

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Embolism; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
[New antithrombotic drugs].
    Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:7

    Topics: Adenosine; Anticoagulants; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin

2012
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2012, Volume: 35, Issue:1

    Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin

2012
Treatment of venous thromboembolism with dabigatran.
    Current opinion in pulmonary medicine, 2012, Volume: 18, Issue:5

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Rivaroxaban; Secondary Prevention; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin

2012
Dabigatran and left atrial appendage thrombus.
    Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:4

    Topics: Antithrombins; Atrial Appendage; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Diseases; Humans; Middle Aged; Thrombosis; Warfarin

2012
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Advances in therapy, 2012, Volume: 29, Issue:6

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
    Coronary artery disease, 2012, Volume: 23, Issue:6

    Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Warfarin

2012
Anticoagulant therapy: basic principles, classic approaches and recent developments.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2012, Volume: 23, Issue:6

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Factor Xa; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudins; Humans; Platelet Aggregation Inhibitors; Thrombin; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamin K; Warfarin

2012
The management of antithrombotic medication in skin surgery.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:9

    Topics: Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Dermatologic Surgical Procedures; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Risk Assessment; Rivaroxaban; Thienopyridines; Thiophenes; Vitamin K; Warfarin

2012
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:3

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Heart Valve Diseases; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Morpholines; Multicenter Studies as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Vitamin K; Warfarin

2012
Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation.
    QJM : monthly journal of the Association of Physicians, 2012, Volume: 105, Issue:10

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Comparative Effectiveness Research; Dabigatran; Drug Monitoring; Embolism; Female; Humans; Male; Middle Aged; Morpholines; Outcome and Process Assessment, Health Care; Pharmacovigilance; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Complications of anticoagulation.
    Disease-a-month : DM, 2012, Volume: 58, Issue:8

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Contamination; Drug Monitoring; Food-Drug Interactions; Hemorrhage; Heparin; Humans; Hypersensitivity; Injections, Subcutaneous; Necrosis; Osteoporosis; Skin Diseases; Subcutaneous Tissue; Thrombocytopenia; Warfarin

2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results.
    Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Evidence-Based Medicine; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Patient Safety; Preventive Health Services; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2012
Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.
    Journal of Zhejiang University. Science. B, 2012, Volume: 13, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiology; Dabigatran; Female; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Risk; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.
    Minerva cardioangiologica, 2012, Volume: 60, Issue:4

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2012
Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
    Canadian family physician Medecin de famille canadien, 2012, Volume: 58, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Decision Support Techniques; Health Status Indicators; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Monitoring, Ambulatory; Self Care; Stroke; Thromboembolism; Vitamin K; Warfarin

2012
Stroke prevention in atrial fibrillation: concepts and controversies.
    Current cardiology reviews, 2012, Volume: 8, Issue:4

    Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Dronedarone; Drug Design; Humans; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2012
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:5

    Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Practice Guidelines as Topic; Pregnancy; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin

2012
[New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Kardiologia polska, 2012, Volume: 70, Issue:10

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Electric Countershock; Factor Xa Inhibitors; Humans; Kidney Failure, Chronic; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin

2012
Comparing new anticoagulants.
    Southern medical journal, 2012, Volume: 105, Issue:12

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Rivaroxaban; Thiophenes; United States; United States Food and Drug Administration; Warfarin

2012
The novel anticoagulants: the surgeons' prospective.
    Surgery, 2013, Volume: 153, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Surgical Procedures, Operative; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin

2013
New oral anticoagulants: which one should my patient use?
    Hematology. American Society of Hematology. Education Program, 2012, Volume: 2012

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Chemistry, Pharmaceutical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Hematology; Humans; Morpholines; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Warfarin

2012
A review of oral anticoagulants in patients with atrial fibrillation.
    Postgraduate medicine, 2012, Volume: 124, Issue:6

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
    The Journal of emergency medicine, 2013, Volume: 45, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Emergencies; Hemorrhage; Humans; Morpholines; Rivaroxaban; Stroke; Thiophenes; United States; United States Food and Drug Administration; Warfarin

2013
Managing new oral anticoagulants in the perioperative and intensive care unit setting.
    Anesthesiology, 2013, Volume: 118, Issue:6

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Critical Care; Dabigatran; Hemorrhage; Humans; Intensive Care Units; Morpholines; Perioperative Care; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2013
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
    European heart journal, 2013, Volume: 34, Issue:23

    Topics: Adenosine; Aspirin; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Warfarin

2013
New anticoagulants in atrial fibrillation management.
    Thrombosis research, 2013, Volume: 131 Suppl 1

    Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Coumarins; Dabigatran; Female; Hematology; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Renal Insufficiency; Sex Factors; Warfarin

2013
Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Hospital practice (1995), 2013, Volume: 41, Issue:1

    Topics: Administration, Oral; Aging; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Hemorrhage; Humans; Meta-Analysis as Topic; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
    Hospital practice (1995), 2013, Volume: 41, Issue:1

    Topics: Administration, Oral; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Hemorrhage; Humans; Middle Aged; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin

2013
Risk versus benefit of non-vitamin K dependent anticoagulants compared to warfarin for the management of atrial fibrillation in the elderly.
    Drugs & aging, 2013, Volume: 30, Issue:7

    Topics: Aged; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Fibrinolytic Agents; Humans; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Warfarin

2013
[Improvements in oral anticoagulant therapy for atrial fibrillation].
    Medicina clinica, 2013, Dec-07, Volume: 141, Issue:11

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Embolism; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Treatment Outcome; Warfarin

2013
Reversal of oral anticoagulation.
    Pharmacotherapy, 2013, Volume: 33, Issue:11

    Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Morpholines; Rivaroxaban; Thiophenes; Warfarin

2013
Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide.
    Journal of medical economics, 2013, Volume: 16, Issue:7

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Embolism; Hemorrhage; Humans; Quality-Adjusted Life Years; Stroke; Warfarin

2013
[Direct oral thrombin inhibitor, "dabigatran"].
    Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:1

    Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Warfarin

2013
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Contributions to nephrology, 2013, Volume: 179

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Disease Management; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Intracranial Embolism; Male; Morpholines; Patient Selection; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Warfarin

2013
Venous thromboembolism management: where do novel anticoagulants fit?
    Current medical research and opinion, 2013, Volume: 29, Issue:7

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor X; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin

2013
Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Endoscopy; Gastrointestinal Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
    Stroke, 2013, Volume: 44, Issue:6 Suppl 1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Humans; Monitoring, Physiologic; Morpholines; Prodrugs; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Vitamin K; Warfarin

2013
[Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Electric Countershock; Enoxaparin; Heparin; Humans; International Normalized Ratio; Morpholines; Phenprocoumon; Practice Guidelines as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin

2013
Managing bleeding in anticoagulated patients in the emergency care setting.
    The Journal of emergency medicine, 2013, Volume: 45, Issue:3

    Topics: Anticoagulants; Antidotes; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Hemorrhage; Hemostasis; Humans; Morpholines; Rivaroxaban; Thiophenes; Warfarin

2013
Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:7 Suppl

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Morpholines; Outcome Assessment, Health Care; Patient Selection; Polymorphism, Genetic; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2013, Volume: 16, Issue:4

    Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Cost-Benefit Analysis; Dabigatran; Drug Costs; Hemorrhage; Humans; Markov Chains; Middle Aged; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Time Factors; Warfarin

2013
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.
    Heart failure reviews, 2014, Volume: 19, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chronic Disease; Dabigatran; Drug Monitoring; Heart Failure; Hemorrhage; Humans; Morpholines; Outcome Assessment, Health Care; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Warfarin

2014
Thromboprophylaxis in patients with pelvic and acetabular fractures: A short review and recommendations.
    Injury, 2013, Volume: 44, Issue:12

    Topics: Acetabulum; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Fondaparinux; Fractures, Bone; Heparin; Humans; Mass Screening; Morpholines; Multiple Trauma; Pelvis; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Vena Cava Filters; Venous Thromboembolism

2013
Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012.
    Postgraduate medicine, 2013, Volume: 125, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin

2013
New alternative anticoagulants in atrial fibrillation: the move beyond warfarin.
    Reviews on recent clinical trials, 2013, Volume: 8, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Humans; Morpholines; Prognosis; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
What are the new therapeutic alternatives to warfarin in atrial fibrillation?
    JPMA. The Journal of the Pakistan Medical Association, 2013, Volume: 63, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pakistan; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Clinical therapeutics, 2013, Volume: 35, Issue:7

    Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Data Interpretation, Statistical; Databases, Bibliographic; Double-Blind Method; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Heart (British Cardiac Society), 2014, Volume: 100, Issue:4

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Preoperative Care; Thromboembolism; Treatment Outcome; Warfarin

2014
Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Journal (Canadian Dental Association), 2013, Volume: 79

    Topics: Administration, Oral; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; International Normalized Ratio; Postoperative Hemorrhage; Pyridines; Surgery, Oral; Tooth Extraction; Warfarin

2013
Disadvantages of VKA and requirements for novel anticoagulants.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Dosage Calculations; Drug Interactions; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Vitamin K; Warfarin

2013
Novel oral anticoagulants in secondary prevention of stroke.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Guidelines as Topic; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin

2013
New oral anticoagulants for the treatment of venous thromboembolism.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin

2013
New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Heparin, Low-Molecular-Weight; Humans; Morpholines; Neoplasms; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin

2013
Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Heparin, Low-Molecular-Weight; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin

2013
NOACs for thromboprophylaxis in medical patients.
    Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Enoxaparin; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Warfarin

2013
Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran.
    Expert review of cardiovascular therapy, 2013, Volume: 11, Issue:9

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Warfarin

2013
Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:10

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Perioperative Care; Stroke; Warfarin

2013
Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation.
    Clinical pharmacology and therapeutics, 2014, Volume: 95, Issue:2

    Topics: Algorithms; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Drug Dosage Calculations; Humans; Morpholines; Pharmacogenetics; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors.
    The American journal of cardiology, 2013, Dec-15, Volume: 112, Issue:12

    Topics: Amidines; Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Warfarin

2013
Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
    Circulation, 2013, Nov-19, Volume: 128, Issue:21

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Dabigatran; Female; Hemoglobins; Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Risk Factors; Treatment Outcome; Venous Thromboembolism; Warfarin

2013
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
    Pharmacogenomics, 2013, Volume: 14, Issue:13

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine; Warfarin

2013
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
    Polskie Archiwum Medycyny Wewnetrznej, 2013, Volume: 123, Issue:11

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Administration Schedule; Fibrinolytic Agents; Forecasting; Humans; Morpholines; Percutaneous Coronary Intervention; Postoperative Care; Postoperative Hemorrhage; Premedication; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin

2013
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    European journal of internal medicine, 2014, Volume: 25, Issue:1

    Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin

2014
An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.
    Journal of the American Heart Association, 2013, Oct-23, Volume: 2, Issue:5

    Topics: Acute Coronary Syndrome; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Risk Assessment; Stroke; Venous Thromboembolism; Warfarin

2013
A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    JAMA internal medicine, 2014, Volume: 174, Issue:1

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Pharmaceutical; Gastrointestinal Hemorrhage; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin

2014
Outpatient management of oral anticoagulation in atrial fibrillation.
    Critical care nursing clinics of North America, 2013, Volume: 25, Issue:4

    Topics: Ambulatory Care; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
[Evidence of novel oral anticoagulants (NOAC)].
    Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11

    Topics: Administration, Ophthalmic; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Infarction; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
New oral anticoagulants in practice: pharmacological and practical considerations.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014, Volume: 14, Issue:3

    Topics: Administration, Oral; Aging; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Complementary Therapies; Dabigatran; Drug Interactions; Drug Monitoring; Humans; International Normalized Ratio; Kidney Diseases; Liver Diseases; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Sex Factors; Stroke; Thiophenes; Warfarin

2014
New oral anticoagulant agents - general features and outcomes in subsets of patients.
    Thrombosis and haemostasis, 2014, Apr-01, Volume: 111, Issue:4

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Morpholines; Patient Selection; Pyrazoles; Pyridines; Pyridones; Risk; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin

2014
Anticoagulation and antiplatelet therapy in acute coronary syndromes.
    Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:2

    Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin

2014
Practical aspects of new oral anticoagulant use in atrial fibrillation.
    Polskie Archiwum Medycyny Wewnetrznej, 2014, Volume: 124, Issue:3

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.
    The Cochrane database of systematic reviews, 2014, Mar-27, Issue:3

    Topics: Amidines; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Drug Administration Schedule; Embolism; Female; Humans; Male; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Stroke; Vitamin K; Warfarin

2014
The newer direct oral anticoagulants: a practical guide.
    Clinical medicine (London, England), 2014, Volume: 14, Issue:2

    Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Warfarin

2014
Anticoagulation in atrial fibrillation.
    BMJ (Clinical research ed.), 2014, Apr-14, Volume: 348

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Medication Adherence; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Anticoagulation: a GP primer on the new oral anticoagulants.
    Australian family physician, 2014, Volume: 43, Issue:5

    Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; General Practice; Hemorrhage; Humans; Kidney; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin

2014
Management of anticoagulation around pacemaker and defibrillator surgery.
    Circulation, 2014, May-20, Volume: 129, Issue:20

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Defibrillators, Implantable; Humans; Intracranial Embolism; Male; Pacemaker, Artificial; Warfarin

2014
Protocol in managing oral surgical patients taking dabigatran.
    Australian dental journal, 2014, Volume: 59, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Treatment; Female; Humans; Male; Oral Surgical Procedures; Tooth Extraction; Warfarin; Withholding Treatment

2014
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
    MMW Fortschritte der Medizin, 2014, Feb-06, Volume: 156, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin

2014
Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
    The American journal of cardiology, 2014, Aug-15, Volume: 114, Issue:4

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin

2014
[Update on current care guideline: atrial fibrillation].
    Duodecim; laaketieteellinen aikakauskirja, 2014, Volume: 130, Issue:12

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Incidence; Morpholines; Practice Guidelines as Topic; Prevalence; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2014
Novel anticoagulants vs warfarin for stroke prevention in atrial fibrillation.
    Cardiovascular & hematological disorders drug targets, 2014, Volume: 14, Issue:1

    Topics: Animals; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Discovery; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin

2014
Oral anticoagulants: the move beyond warfarin.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2014, Volume: 46, Issue:5

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Warfarin

2014
Target-specific oral anticoagulants: practice issues for the clinician.
    Hospital practice (1995), 2014, Volume: 42, Issue:3

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; Medication Adherence; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin

2014
Perioperative management of oral anticoagulants: a focus on target-specific oral anticoagulants.
    Hospital practice (1995), 2014, Volume: 42, Issue:3

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Humans; Kidney Function Tests; Morpholines; Perioperative Period; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin

2014
Switching between oral anticoagulants.
    Hospital practice (1995), 2014, Volume: 42, Issue:3

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; United States; Warfarin

2014
[Stroke prevention after stroke in patients with atrial fibrillation: a case-based review].
    Orvosi hetilap, 2014, Oct-19, Volume: 155, Issue:42

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Vitamin K; Warfarin

2014
Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
    Canadian family physician Medecin de famille canadien, 2014, Volume: 60, Issue:11

    Topics: Acute Disease; Administration, Oral; Anticoagulants; Antidotes; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Family Practice; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Warfarin

2014
[More with atrial fibrillation, anticoagulants since the coming of NOAK ].
    Lakartidningen, 2015, Jan-06, Volume: 112

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Prescriptions; Drug Utilization; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Warfarin

2015
Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Annual review of medicine, 2015, Volume: 66

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin

2015
[Anticoagulant therapy in secondary prevention of coronary events].
    Vnitrni lekarstvi, 2014, Volume: 60, Issue:12

    Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Ticlopidine; Warfarin

2014
Overview of the new oral anticoagulants: opportunities and challenges.
    Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:5

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Sensitivity and Specificity; Stroke; Thiazoles; Thiophenes; Thromboembolism; Warfarin

2015
Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal.
    Archives of pathology & laboratory medicine, 2015, Volume: 139, Issue:5

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Humans; Laboratories; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin

2015
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation.
    Annals of hematology, 2016, Volume: 95, Issue:3

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; beta-Alanine; Clinical Decision-Making; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Warfarin

2016

Trials

27 trial(s) available for beta-alanine and warfarin

ArticleYear
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Circulation, 2011, Jan-18, Volume: 123, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Echocardiography, Transesophageal; Electric Countershock; Electric Stimulation Therapy; Hemorrhage; Humans; Incidence; Retrospective Studies; Stroke; Warfarin

2011
Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:4

    Topics: Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Japan; Male; Stroke; Warfarin

2011
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Circulation, 2011, May-31, Volume: 123, Issue:21

    Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Risk Factors; Time Factors; Warfarin

2011
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
    Annals of internal medicine, 2011, Nov-15, Volume: 155, Issue:10

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cause of Death; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Warfarin

2011
Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Circulation, 2012, Feb-07, Volume: 125, Issue:5

    Topics: Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Female; Heart Arrest; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Single-Blind Method; Warfarin

2012
[Expectation to and problems of thrombin inhibitor].
    Rinsho shinkeigaku = Clinical neurology, 2011, Volume: 51, Issue:11

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Stroke; Warfarin

2011
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
    Stroke, 2012, Volume: 43, Issue:6

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Radiography; Risk Factors; Warfarin

2012
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Circulation, 2012, Jul-17, Volume: 126, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Brain Ischemia; Cardiac Pacing, Artificial; Cataract Extraction; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Risk Factors; Stroke; Thromboembolism; Warfarin

2012
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.
    European heart journal, 2013, Volume: 34, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Humans; Life Expectancy; Quality-Adjusted Life Years; Stroke; Sweden; Warfarin

2013
Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:10

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Humans; Male; Middle Aged; Perioperative Care; Thromboembolism; Warfarin

2012
A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 2013, Volume: 36, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Middle Aged; Perioperative Care; Premedication; Thrombosis; Treatment Outcome; Warfarin

2013
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?
    Journal of thrombosis and thrombolysis, 2013, Volume: 35, Issue:2

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Thrombin; Warfarin

2013
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
    The New England journal of medicine, 2013, Feb-21, Volume: 368, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; beta-Alanine; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Intention to Treat Analysis; International Normalized Ratio; Male; Middle Aged; Recurrence; Risk; Venous Thromboembolism; Warfarin; Young Adult

2013
Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.
    International journal of cardiology, 2013, Oct-03, Volume: 168, Issue:3

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Prospective Studies; Quality of Life; Warfarin

2013
Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Canada; Catheter Ablation; Comorbidity; Dabigatran; Decision Making; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Humans; Postoperative Complications; Premedication; Risk Factors; Thromboembolism; Treatment Outcome; United States; Warfarin

2013
Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Journal of the American College of Cardiology, 2013, Sep-03, Volume: 62, Issue:10

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Risk Factors; Stroke; Treatment Outcome; Warfarin

2013
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.
    European journal of heart failure, 2013, Volume: 15, Issue:9

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Risk Factors; Stroke; Warfarin

2013
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Clinical therapeutics, 2013, Volume: 35, Issue:7

    Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Data Interpretation, Statistical; Databases, Bibliographic; Double-Blind Method; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey.
    Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Costs and Cost Analysis; Dabigatran; Drug Substitution; Female; Humans; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Warfarin

2014
Dabigatran versus warfarin in patients with mechanical heart valves.
    The New England journal of medicine, 2013, Sep-26, Volume: 369, Issue:13

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Stroke; Thromboembolism; Warfarin

2013
Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.
    Circulation, 2013, Nov-12, Volume: 128, Issue:20

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cause of Death; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Warfarin

2013
Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
    Circulation, 2013, Nov-19, Volume: 128, Issue:21

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Dabigatran; Female; Hemoglobins; Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Risk Factors; Treatment Outcome; Venous Thromboembolism; Warfarin

2013
Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.
    Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2013, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Choice Behavior; Dabigatran; Decision Support Techniques; Female; Humans; Male; Middle Aged; Warfarin

2013
Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
    Circulation, 2014, Mar-04, Volume: 129, Issue:9

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Embolism; Female; Glomerular Filtration Rate; Humans; Internationality; Kidney; Male; Middle Aged; Models, Biological; Risk Factors; Stroke; Treatment Outcome; Warfarin

2014
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
    Circulation, 2014, Feb-18, Volume: 129, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Recurrence; Risk Factors; Venous Thromboembolism; Warfarin; Young Adult

2014
Warfarin or dabigatran for treatment of atrial fibrillation.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:7

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Europe; Hemorrhage; Humans; Software; Thromboembolism; Warfarin

2014
Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:10

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Case-Control Studies; Dabigatran; Female; Hemoglobins; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; Postoperative Hemorrhage; Prospective Studies; Warfarin

2014

Other Studies

261 other study(ies) available for beta-alanine and warfarin

ArticleYear
When a virtue becomes a problem. The new oral anticoagulants.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:8

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Therapy; Humans; Medication Adherence; Risk; Vitamin K; Warfarin

2010
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Annals of internal medicine, 2011, Jan-04, Volume: 154, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Markov Chains; Myocardial Infarction; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Stroke; Warfarin

2011
Warfarin or not.
    The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:4

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Pulmonary Embolism; Venous Thromboembolism; Warfarin

2010
The difference between Tdap and DTaP; dabigatran versus warfarin.
    JAAPA : official journal of the American Academy of Physician Assistants, 2011, Volume: 24, Issue:1

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diphtheria-Tetanus-acellular Pertussis Vaccines; Humans; Product Surveillance, Postmarketing; Warfarin

2011
Next generation anticoagulants may push warfarin to the wayside.
    Managed care (Langhorne, Pa.), 2011, Volume: 20, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Drug Evaluation; Humans; Medication Adherence; Stroke; Warfarin

2011
New drug offers warfarin alternative for atrial fibrillation. An immediate switch is right for some people, but not necessary for all.
    Harvard heart letter : from Harvard Medical School, 2011, Volume: 21, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug and Narcotic Control; Drug Approval; Humans; United States; United States Food and Drug Administration; Warfarin

2011
Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran.
    The New England journal of medicine, 2011, May-12, Volume: 364, Issue:19

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Embolism; Hemorrhage; Humans; Stroke; Therapeutic Equivalency; United States; United States Food and Drug Administration; Warfarin

2011
Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Annals of internal medicine, 2011, Apr-19, Volume: 154, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Fibrinolytic Agents; Health Care Costs; Humans; Stroke; Warfarin

2011
Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Annals of internal medicine, 2011, Apr-19, Volume: 154, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Fibrinolytic Agents; Health Care Costs; Humans; Stroke; Warfarin

2011
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Circulation, 2011, Jun-07, Volume: 123, Issue:22

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Decision Trees; Hemorrhage; Humans; Markov Chains; Risk Factors; Stroke; Warfarin

2011
Switching patients from warfarin to dabigatran therapy: to RE-LY or not to rely.
    International journal of cardiology, 2012, Jan-26, Volume: 154, Issue:2

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coronary Thrombosis; Dabigatran; Humans; Male; Recurrence; Stroke; Ultrasonography; Warfarin

2012
Ask the doctor. For several years, I have been taking warfarin because of atrial fibrillation. I recently suffered several nosebleeds, which took two days to control. The trauma of those episodes makes me want to swear off warfarin, but I am not sure what
    Harvard health letter, 2011, Volume: 36, Issue:7

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Health Knowledge, Attitudes, Practice; Hemorrhage; Humans; Patient Education as Topic; Warfarin

2011
New options in anticoagulation for atrial fibrillation.
    The New England journal of medicine, 2011, Sep-08, Volume: 365, Issue:10

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Intention to Treat Analysis; Intracranial Hemorrhages; Morpholines; Rivaroxaban; Thiophenes; Warfarin

2011
A new era for anticoagulation in atrial fibrillation.
    The New England journal of medicine, 2011, Sep-15, Volume: 365, Issue:11

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin

2011
Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Pharmacotherapy, 2011, Volume: 31, Issue:8

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Female; Hemorrhage; Humans; Male; Middle Aged; Stroke; Warfarin

2011
The use of dabigatran immediately after atrial fibrillation ablation.
    Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:3

    Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Tolerance; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombin; Thromboembolism; Treatment Outcome; Warfarin

2012
Dabigatran: will it change clinical practice?
    Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:10

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Embolism; Humans; Stroke; United States; Warfarin

2011
Lack of an antagonist to reverse the action of dabigatran.
    QJM : monthly journal of the Association of Physicians, 2012, Volume: 105, Issue:2

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Hemorrhage; Humans; Morpholines; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Warfarin

2012
Learning the respective roles of warfarin and dabigatran to prevent stroke in patients with nonvalvular atrial fibrillation.
    Annals of internal medicine, 2011, Nov-15, Volume: 155, Issue:10

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Female; Hemorrhage; Humans; Male; Stroke; Warfarin

2011
Dabigatran (OCTOBER 2011).
    Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:12

    Topics: Benzimidazoles; beta-Alanine; Embolism; Humans; Stroke; Warfarin

2011
[New treatments for venous thromboembolic disease].
    Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis; Warfarin

2011
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
    Thrombosis and haemostasis, 2012, Volume: 107, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Cohort Studies; Computer Simulation; Dabigatran; Decision Making, Computer-Assisted; Denmark; Humans; Intracranial Hemorrhages; Morpholines; Population Groups; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2012
The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
    International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Thrombin; Warfarin

2012
Letter by Govindarajan and Salgado regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (
    Circulation, 2012, Jan-24, Volume: 125, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2012
Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) tri
    Circulation, 2012, Jan-24, Volume: 125, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2012
Letter by Reiffel regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial".
    Circulation, 2012, Jan-24, Volume: 125, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2012
Anticoagulation for atrial fibrillation ablation: what is the optimal strategy?
    Journal of the American College of Cardiology, 2012, Mar-27, Volume: 59, Issue:13

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Registries; Warfarin

2012
Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Journal of the American College of Cardiology, 2012, Mar-27, Volume: 59, Issue:13

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Feasibility Studies; Female; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Prospective Studies; Registries; Thromboembolism; Treatment Outcome; Warfarin

2012
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Stroke, 2012, Volume: 43, Issue:3

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Dose-Response Relationship, Drug; Drug Costs; Female; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Markov Chains; Models, Statistical; Monte Carlo Method; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Stroke; Warfarin

2012
New directions in anticoagulation.
    The American journal of medicine, 2012, Volume: 125, Issue:3

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
    Journal of the American College of Cardiology, 2012, Feb-28, Volume: 59, Issue:9

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Electrocardiography; Embolism; Female; Follow-Up Studies; Heart Rate; Humans; Male; Randomized Controlled Trials as Topic; Stroke; Tachycardia, Paroxysmal; Time Factors; Treatment Outcome; Warfarin

2012
Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Age and ageing, 2012, Volume: 41, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Costs and Cost Analysis; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Prospective Studies; Risk Factors; Stroke; Treatment Outcome; Warfarin

2012
Dabigatran (OCTOBER 2011).
    Cleveland Clinic journal of medicine, 2012, Volume: 79, Issue:3

    Topics: Benzimidazoles; beta-Alanine; Embolism; Humans; Stroke; Warfarin

2012
New antithrombotic drugs: a revolution in stroke management.
    Cardiovascular journal of Africa, 2012, Volume: 23, Issue:2

    Topics: Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Approval; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Monitoring, Physiologic; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Annals of neurology, 2012, Volume: 71, Issue:5

    Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Drug Interactions; Fibrinolytic Agents; Mice; Mice, Inbred C57BL; Stroke; Tissue Plasminogen Activator; Warfarin

2012
[Update on current care guidelines: atrial fibrillation].
    Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dronedarone; Finland; Humans; Morpholines; Practice Guidelines as Topic; Rivaroxaban; Thiophenes; Warfarin

2012
Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.
    Journal of medical economics, 2012, Volume: 15, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost Control; Dabigatran; Endpoint Determination; Health Expenditures; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; United States; Warfarin

2012
Avoiding adverse events with dabigatran by careful selection of eligible patients.
    The Medical journal of Australia, 2012, Apr-16, Volume: 196, Issue:7

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Hemorrhage; Humans; Patient Selection; Stroke; Warfarin

2012
Dabigatran versus warfarin after mechanical mitral valve replacement in the swine model.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2012, Volume: 25, Issue:3

    Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Evaluation, Preclinical; Female; Heart Valve Prosthesis; Hemorrhage; Male; Mitral Valve; Models, Animal; Sus scrofa; Thrombosis; Warfarin

2012
Letter by Freeman et al regarding article, "Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY Trial".
    Stroke, 2012, Volume: 43, Issue:7

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Intracranial Hemorrhages; Male; Warfarin

2012
Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2012, Volume: 113, Issue:4

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Biological Availability; Blood Coagulation Tests; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Half-Life; Humans; Morpholines; Narcotics; Oral Hemorrhage; Oral Surgical Procedures; Postoperative Hemorrhage; Rivaroxaban; Thiophenes; Warfarin

2012
An anticoagulation option for nonvalvular atrial fibrillation.
    The Journal of family practice, 2012, Volume: 61, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Decision Support Techniques; Health Status Indicators; Humans; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Stroke; Warfarin

2012
Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012, Volume: 27, Issue:6

    Topics: Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Fibrinolytic Agents; Humans; Prospective Studies; Stroke; Thromboembolism; Warfarin

2012
Anticoagulation, novel agents, and procedures: can we pardon the interruption?
    Circulation, 2012, Jul-17, Volume: 126, Issue:3

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Thromboembolism; Warfarin

2012
Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Genotype; Humans; Stroke; Warfarin

2012
Dabigatran: uncharted waters and potential harms.
    Annals of internal medicine, 2012, Jul-03, Volume: 157, Issue:1

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Pharmacovigilance; Randomized Controlled Trials as Topic; Thrombin; Thromboembolism; Warfarin

2012
Letter by Stollberger and Finsterer regarding article, "intracranial hemorrhage in patients with atrial fibrillation during anticoagulation with Warfarin or Dabigatran: the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial".
    Stroke, 2012, Volume: 43, Issue:9

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Intracranial Hemorrhages; Male; Warfarin

2012
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
    Circulation. Cardiovascular quality and outcomes, 2012, Jul-01, Volume: 5, Issue:4

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Evidence-Based Medicine; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Time Factors; Treatment Outcome; Warfarin

2012
How country-specific should a country-specific cost-effectiveness analysis be?
    European heart journal, 2013, Volume: 34, Issue:3

    Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticagrelor; Warfarin

2013
Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation.
    Journal of evaluation in clinical practice, 2013, Volume: 19, Issue:5

    Topics: Adult; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Eligibility Determination; Fees, Pharmaceutical; Female; Health Care Surveys; Hemorrhage; Humans; Male; Middle Aged; Patient Preference; Patient Selection; Practice Patterns, Physicians'; Surveys and Questionnaires; United States; Warfarin

2013
[Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Kardiologiia, 2012, Volume: 52, Issue:7

    Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin

2012
Dabigatran: rational dose individualisation and monitoring guidance is needed.
    The New Zealand medical journal, 2012, Jun-29, Volume: 125, Issue:1357

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Humans; New Zealand; Warfarin

2012
A comparison of bleeding complications post-ablation between warfarin and dabigatran.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2012, Volume: 35, Issue:1

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Stroke; Treatment Outcome; Warfarin

2012
New anticoagulants.
    British dental journal, 2012, Volume: 213, Issue:3

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; Morpholines; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
Novel oral anticoagulants for stroke prevention in atrial fibrillation.
    European heart journal, 2012, Volume: 33, Issue:12

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin

2012
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Canada; Clinical Trials as Topic; Cost-Benefit Analysis; Dabigatran; Embolism; Humans; Markov Chains; Models, Economic; Morpholines; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2012
Evaluating and assessing dabigatran drug interactions.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012, Volume: 27, Issue:7

    Topics: Antithrombins; Benzimidazoles; beta-Alanine; Consultants; Cytochrome P-450 Enzyme System; Dabigatran; Drug Interactions; Drug Monitoring; Female; Humans; International Normalized Ratio; Middle Aged; Pharmaceutical Services; Pharmacists; Professional Role; Warfarin

2012
National trends in oral anticoagulant use in the United States, 2007 to 2011.
    Circulation. Cardiovascular quality and outcomes, 2012, Sep-01, Volume: 5, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Costs; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Guideline Adherence; Health Care Surveys; Health Expenditures; Humans; Medical Audit; Middle Aged; Off-Label Use; Practice Guidelines as Topic; Practice Patterns, Physicians'; Preventive Health Services; Thromboembolism; Time Factors; United States; Warfarin

2012
Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.
    Revista espanola de cardiologia (English ed.), 2012, Volume: 65, Issue:10

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Embolism; Female; Humans; Male; Markov Chains; Spain; Stroke; Vitamin K; Warfarin

2012
Dabigatran emerges as safe and effective warfarin alternative. The recently approved drug is more expensive, but appears to be more predictable.
    Heart advisor, 2011, Volume: 14, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Drug Interactions; Humans; Stroke; United States; United States Food and Drug Administration; Venous Thromboembolism; Warfarin

2011
Safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing ablation for atrial fibrillation.
    Journal of the American College of Cardiology, 2012, Sep-18, Volume: 60, Issue:12

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Registries; Warfarin

2012
Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2012, Volume: 35, Issue:3

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Female; Heparin; Humans; Linear Models; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Risk Factors; Treatment Outcome; Warfarin

2012
Dabigatran in atrial fibrillation: incremental benefit over a time horizon of 5 or 10 years.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2013, Volume: 14, Issue:9

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Humans; Markov Chains; Quality-Adjusted Life Years; Stroke; Warfarin

2013
Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 36, Issue:1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Morpholines; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; United States; Warfarin

2013
Periprocedural anticoagulant management.
    Hospital practice (1995), 2012, Volume: 40, Issue:3

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Coronary Restenosis; Dabigatran; Heart Valve Prosthesis; Hemorrhage; Humans; Morpholines; Neoplasms; Perioperative Care; Risk Assessment; Rivaroxaban; Stents; Thiophenes; Venous Thromboembolism; Warfarin

2012
The new oral anticoagulants: a challenge for hospital formularies.
    Hospital practice (1995), 2012, Volume: 40, Issue:3

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Formularies, Hospital as Topic; Humans; Morpholines; Pennsylvania; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2012
New ESC guidelines on atrial fibrillation accept reality of next generation of anti-coagulants.
    Cardiovascular journal of Africa, 2012, Volume: 23, Issue:9

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Europe; Humans; Postoperative Complications; Practice Guidelines as Topic; United States; Vascular Surgical Procedures; Venous Thromboembolism; Warfarin

2012
Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong.
    Clinical cardiology, 2012, Volume: 35, Issue:12

    Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hong Kong; Humans; Male; Quality of Life; Retrospective Studies; Stroke; Warfarin

2012
[Introduction].
    Revista clinica espanola, 2012, Volume: 212 Suppl 1

    Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin

2012
[New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
    Revista clinica espanola, 2012, Volume: 212 Suppl 1

    Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin

2012
[Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:11

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Humans; Intracranial Embolism; Morpholines; Rivaroxaban; Thiophenes; Warfarin

2012
Rivaroxaban and atrial fibrillation: continue to use warfarin or in some cases, dabigatran.
    Prescrire international, 2012, Volume: 21, Issue:132

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Humans; Kidney; Morpholines; Rivaroxaban; Thiophenes; Warfarin

2012
Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Heart rhythm, 2013, Volume: 10, Issue:4

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Case-Control Studies; Catheter Ablation; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Electrocardiography; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Care; Predictive Value of Tests; Preoperative Care; Reference Values; Risk Assessment; Severity of Illness Index; Thromboembolism; Treatment Outcome; Warfarin

2013
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
    Klinicheskaia meditsina, 2012, Volume: 90, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin

2012
Transitions of care in anticoagulation management for patients with atrial fibrillation.
    Hospital practice (1995), 2012, Volume: 40, Issue:4

    Topics: Administration, Oral; Aftercare; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Continuity of Patient Care; Dabigatran; Drug Monitoring; Drug Substitution; Emergencies; Hemorrhage; Humans; Morpholines; Patient Education as Topic; Rivaroxaban; Stroke; Thiophenes; Warfarin

2012
[New anticoagulants--should we have a little bit of cold water in the blood?].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Feb-19, Volume: 133, Issue:4

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Drug Monitoring; Factor Xa Inhibitors; Humans; Medication Adherence; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2013
Extended treatment of venous thromboembolism.
    The New England journal of medicine, 2013, Feb-21, Volume: 368, Issue:8

    Topics: Benzimidazoles; beta-Alanine; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Pyrazoles; Pyridones; Venous Thromboembolism; Warfarin

2013
Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia.
    The New England journal of medicine, 2013, Feb-28, Volume: 368, Issue:9

    Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Platelet Aggregation Inhibitors; Telangiectasia, Hereditary Hemorrhagic; Warfarin

2013
Dabigatran "non-inferior" to warfarin, but only just.
    BMJ (Clinical research ed.), 2013, Feb-27, Volume: 346

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Pulmonary Embolism; Treatment Outcome; Venous Thrombosis; Warfarin

2013
Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
    Hospital practice (1995), 2013, Volume: 41, Issue:1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Hemorrhage; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Antidotes edge closer to reversing effects of new blood thinners.
    Nature medicine, 2013, Volume: 19, Issue:3

    Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa; Humans; Pyrazoles; Pyridones; Recombinant Proteins; Vitamin K; Warfarin

2013
Dabigatran and postmarketing reports of bleeding.
    The New England journal of medicine, 2013, Apr-04, Volume: 368, Issue:14

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin

2013
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation--a real patient data analysis in a Hong Kong teaching hospital.
    Clinical cardiology, 2013, Volume: 36, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Drug Utilization; Drug Utilization Review; Female; Health Expenditures; Hong Kong; Hospital Costs; Hospitals, Teaching; Humans; Male; Middle Aged; Preventive Health Services; Retrospective Studies; Stroke; Treatment Outcome; Warfarin

2013
Letter by David et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) Randomized Trial".
    Circulation, 2013, Mar-19, Volume: 127, Issue:11

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Thromboembolism; Warfarin

2013
Letter by Hjemdahl et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial".
    Circulation, 2013, Mar-19, Volume: 127, Issue:11

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Thromboembolism; Warfarin

2013
DRESS syndrome induced by acenocoumarol with tolerance to warfarin and dabigatran: a case report.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:5

    Topics: Acenocoumarol; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Eruptions; Eosinophilia; Exanthema; Humans; Male; Venous Thromboembolism; Warfarin

2013
Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Annals of emergency medicine, 2013, Volume: 61, Issue:4

    Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Female; Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Stroke; Warfarin

2013
Economic appraisal of dabigatran as first-line therapy for stroke prevention in atrial fibrillation.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2013, Feb-15, Volume: 103, Issue:4

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Female; Humans; International Normalized Ratio; Male; Markov Chains; Myocardial Infarction; Quality-Adjusted Life Years; South Africa; Stroke; Warfarin

2013
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation.
    Stroke, 2013, Volume: 44, Issue:6

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Dose-Response Relationship, Drug; Humans; Markov Chains; Models, Statistical; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; United States; Warfarin

2013
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
    Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:3

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Confidence Intervals; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Intraoperative Care; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Registries; Risk Assessment; Severity of Illness Index; Survival Rate; Thromboembolism; Thrombolytic Therapy; Treatment Outcome; Warfarin

2013
Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Journal of cardiovascular electrophysiology, 2013, Volume: 24, Issue:8

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Warfarin

2013
The use, misuse and abuse of dabigatran.
    The Medical journal of Australia, 2013, Apr-15, Volume: 198, Issue:7

    Topics: Advertising; Anticoagulants; Antithrombins; Aspirin; Australia; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Insufficiency; Research Design; Selection Bias; Stroke; Warfarin

2013
Is there really misuse and abuse of dabigatran?
    The Medical journal of Australia, 2013, Apr-15, Volume: 198, Issue:7

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Research Design; Stroke; Warfarin

2013
Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Cerebrovascular diseases (Basel, Switzerland), 2013, Volume: 35, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Computer Simulation; Dabigatran; Decision Support Techniques; Decision Trees; Female; France; Health Services Research; Humans; Incidence; Male; Models, Statistical; Multivariate Analysis; Outcome and Process Assessment, Health Care; Prevalence; Registries; Risk Factors; Stroke; Time Factors; Treatment Outcome; Warfarin

2013
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:1

    Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood-Brain Barrier; Cerebral Arteries; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Humans; Ischemia; Mice; Mice, Inbred C57BL; Rats; Stroke; Thrombolytic Therapy; Warfarin

2013
A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillation.
    PharmacoEconomics, 2013, Volume: 31, Issue:7

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Stroke; Warfarin

2013
Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation.
    Clinical pharmacology and therapeutics, 2013, Volume: 94, Issue:2

    Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Comorbidity; Computer Simulation; Dabigatran; Female; Hemorrhage; Humans; Male; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Time Factors; Warfarin

2013
Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3

    Topics: Adult; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Embolism; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Premedication; Retrospective Studies; Risk Assessment; Stroke; Tennessee; Treatment Outcome; Warfarin

2013
Dabigatran bleed risk with closed head injuries: are we prepared?
    Journal of neurosurgery, 2013, Volume: 119, Issue:3

    Topics: Accidental Falls; Adult; Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage, Traumatic; Clinical Protocols; Craniocerebral Trauma; Dabigatran; Female; Humans; Male; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Warfarin; Young Adult

2013
Pharmacologic interventions for reversing the effects of oral anticoagulants.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, May-15, Volume: 70, Issue:10 Suppl 1

    Topics: Administration, Oral; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Blood Loss, Surgical; Dabigatran; Drug Therapy, Combination; Emergencies; Hemorrhage; Humans; International Normalized Ratio; Morpholines; Plasma; Pyrazoles; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Thromboembolism; Treatment Outcome; Vitamin K 1; Warfarin

2013
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.
    Circulation, 2013, Mar-19, Volume: 127, Issue:11

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Thromboembolism; Warfarin

2013
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
    The American journal of cardiology, 2013, Aug-01, Volume: 112, Issue:3

    Topics: Academic Medical Centers; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Drug Substitution; Female; Humans; Male; Referral and Consultation; Stroke; United States; Warfarin

2013
Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.
    Journal of cardiovascular electrophysiology, 2013, Volume: 24, Issue:8

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Humans; Male; Warfarin

2013
Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.
    Circulation. Cardiovascular imaging, 2013, May-01, Volume: 6, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Substitution; Echocardiography; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mitral Valve Stenosis; Rheumatic Heart Disease; Thrombosis; Treatment Outcome; Warfarin

2013
Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.
    Circulation, 2013, Jun-18, Volume: 127, Issue:24

    Topics: Aged; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Computer Simulation; Coronary Occlusion; Cost-Benefit Analysis; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Markov Chains; Models, Statistical; Ontario; Percutaneous Coronary Intervention; Quality-Adjusted Life Years; Risk Factors; Stroke; Warfarin

2013
Placing a value on new technologies.
    Circulation, 2013, Jun-18, Volume: 127, Issue:24

    Topics: Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coronary Occlusion; Dabigatran; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Male; Percutaneous Coronary Intervention; Stroke; Transplantation; Warfarin

2013
Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE.
    Evidence-based medicine, 2014, Volume: 19, Issue:1

    Topics: Benzimidazoles; beta-Alanine; Female; Humans; Male; Venous Thromboembolism; Warfarin

2014
Extended anticoagulation in venous thromboembolism.
    The New England journal of medicine, 2013, 06-13, Volume: 368, Issue:24

    Topics: Benzimidazoles; beta-Alanine; Female; Humans; Male; Venous Thromboembolism; Warfarin

2013
Extended anticoagulation in venous thromboembolism.
    The New England journal of medicine, 2013, 06-13, Volume: 368, Issue:24

    Topics: Benzimidazoles; beta-Alanine; Female; Humans; Male; Venous Thromboembolism; Warfarin

2013
Extended anticoagulation in venous thromboembolism.
    The New England journal of medicine, 2013, 06-13, Volume: 368, Issue:24

    Topics: Benzimidazoles; beta-Alanine; Female; Humans; Male; Venous Thromboembolism; Warfarin

2013
Extended anticoagulation in venous thromboembolism.
    The New England journal of medicine, 2013, 06-13, Volume: 368, Issue:24

    Topics: Benzimidazoles; beta-Alanine; Female; Humans; Male; Venous Thromboembolism; Warfarin

2013
Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Middle Aged; Morpholines; Patient Safety; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin

2013
Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:3

    Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Complications; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin

2013
Dabigatran and mechanical valves: less effective and more risky than warfarin.
    Prescrire international, 2013, Volume: 22, Issue:138

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Postoperative Complications; Thrombosis; Warfarin

2013
Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials.
    Journal of medical economics, 2013, Volume: 16, Issue:9

    Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost Savings; Cost-Benefit Analysis; Dabigatran; Drug Costs; Drug Utilization; Female; Humans; Male; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; United States; Warfarin

2013
RE-LYing on dabigatran for periprocedural anticoagulation: is it safe?
    Pacing and clinical electrophysiology : PACE, 2013, Volume: 36, Issue:11

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Embolism; Intracranial Thrombosis; Male; Warfarin

2013
[New anticoagulants, new emergencies?].
    Praxis, 2013, Jul-24, Volume: 102, Issue:15

    Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Female; Hemorrhage; Humans; Male; Warfarin

2013
Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Journal of cardiovascular electrophysiology, 2013, Volume: 24, Issue:10

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cardiac Pacing, Artificial; Dabigatran; Defibrillators, Implantable; Device Removal; Drug Administration Schedule; Electric Countershock; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Prosthesis Implantation; Reoperation; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Warfarin

2013
Just because you can, does that mean you should?
    Journal of cardiovascular electrophysiology, 2013, Volume: 24, Issue:10

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Cardiac Pacing, Artificial; Defibrillators, Implantable; Electric Countershock; Female; Humans; Male; Warfarin

2013
Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.
    Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Thromboembolism; Warfarin

2013
Should the newer oral anticoagulants be withheld from patients with valvular AF?
    Chest, 2013, Volume: 144, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Heart Valve Diseases; Humans; International Normalized Ratio; Morpholines; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Anticoagulation-associated upper gastrointestinal haemorrhage.
    Internal medicine journal, 2013, Volume: 43, Issue:8

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Medical Audit; Upper Gastrointestinal Tract; Warfarin

2013
Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers.
    Journal of medical economics, 2013, Volume: 16, Issue:10

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2013
Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
    Stroke, 2013, Volume: 44, Issue:10

    Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Contrast Media; Dabigatran; Iopamidol; Male; Mice; Radiography, Dual-Energy Scanned Projection; Time Factors; Warfarin

2013
Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Circulation. Cardiovascular quality and outcomes, 2013, Sep-01, Volume: 6, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chi-Square Distribution; Dabigatran; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Odds Ratio; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome; Warfarin

2013
The promise of pharmacoepidemiology in helping clinicians assess drug risk.
    Circulation, 2013, Aug-13, Volume: 128, Issue:7

    Topics: Administration, Oral; Advertising; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Confounding Factors, Epidemiologic; Dabigatran; Decision Making; Evidence-Based Medicine; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pharmacoepidemiology; Product Surveillance, Postmarketing; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Rivaroxaban; Therapeutic Equivalency; Thiophenes; United States; United States Food and Drug Administration; Warfarin

2013
The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
    Pacing and clinical electrophysiology : PACE, 2013, Volume: 36, Issue:11

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Female; Humans; Incidence; Intracranial Embolism; Intracranial Thrombosis; Japan; Male; Middle Aged; Premedication; Prospective Studies; Risk Factors; Treatment Outcome; Warfarin

2013
New oral anticoagulants in heart failure.
    European journal of heart failure, 2013, Volume: 15, Issue:9

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Failure; Humans; Male; Stroke; Warfarin

2013
Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.
    Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Thromboembolism; Warfarin

2013
Dabigatran - neurosurgical anathema?
    The Medical journal of Australia, 2013, Aug-19, Volume: 199, Issue:4

    Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Male; Risk Assessment; Stroke; Thrombosis; Warfarin

2013
Dabigatran and mechanical heart valves--not as easy as we hoped.
    The New England journal of medicine, 2013, Sep-26, Volume: 369, Issue:13

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2013
Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:12

    Topics: Acute Kidney Injury; Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Disease Models, Animal; Hemorrhage; Kidney; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Warfarin

2014
The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation.
    Cerebrovascular diseases (Basel, Switzerland), 2013, Volume: 36, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2013
Anticoagulation therapy: Results of RE-ALIGN disappoint.
    Nature reviews. Cardiology, 2013, Volume: 10, Issue:11

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2013
A comparison of methods for estimating glomerular filtration rate for a population in Hawai'i with non-valvular atrial fibrillation.
    Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health, 2013, Volume: 72, Issue:9 Suppl 4

    Topics: Aged, 80 and over; Anticoagulants; Arginine; Asian People; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Glomerular Filtration Rate; Hawaii; Humans; Male; Morpholines; Pipecolic Acids; Retrospective Studies; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin

2013
Acute kidney injury: renal hazards of anticoagulant therapy.
    Nature reviews. Nephrology, 2013, Volume: 9, Issue:11

    Topics: Acute Kidney Injury; Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Rats; Warfarin

2013
Anticoagulation without monitoring.
    American journal of clinical pathology, 2013, Volume: 140, Issue:5

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Hemorrhage; Heparin; Humans; Morpholines; Pharmacovigilance; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Warfarin

2013
Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead.
    Heart (British Cardiac Society), 2014, Volume: 100, Issue:4

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Preoperative Care; Thromboembolism; Warfarin

2014
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.
    Clinical drug investigation, 2014, Volume: 34, Issue:1

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Factor Xa Inhibitors; Health Care Costs; Humans; Italy; Markov Chains; Morpholines; Pyrazoles; Pyridones; Quality of Life; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2014
Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation.
    Circulation. Cardiovascular quality and outcomes, 2013, Volume: 6, Issue:6

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Humans; Models, Statistical; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Thiophenes; United States; Warfarin

2013
Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Journal of neuroscience research, 2014, Volume: 92, Issue:1

    Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Disease Models, Animal; Fibrinolytic Agents; Intracranial Hemorrhages; Male; Rats; Rats, Wistar; Stroke; Tissue Plasminogen Activator; Warfarin

2014
[Prevention and treatment of major bleeding during anticoagulation].
    Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11

    Topics: Administration, Oral; Alcohol Drinking; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Diabetes Mellitus; Drug Therapy, Combination; Factor IX; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Risk Assessment; Risk Factors; Smoking; Vitamin K; Warfarin

2013
New oral anticoagulants: their role and future.
    Clinical medicine (London, England), 2013, Volume: 13 Suppl 6

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Warfarin

2013
Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database.
    Thrombosis and haemostasis, 2014, May-05, Volume: 111, Issue:5

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; Practice Guidelines as Topic; Stroke; Survival Analysis; Thromboembolism; Treatment Outcome; Warfarin

2014
Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead. The authors' reply.
    Heart (British Cardiac Society), 2014, Volume: 100, Issue:4

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Preoperative Care; Thromboembolism; Warfarin

2014
ACP Journal Club. Dabigatran increased bleeding and stroke compared with warfarin after mechanical heart valve implantation.
    Annals of internal medicine, 2013, Dec-17, Volume: 159, Issue:12

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2013
Direct oral anticoagulants for acute venous thromboembolism: closing the circle?
    Circulation, 2014, Feb-18, Volume: 129, Issue:7

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Venous Thromboembolism; Warfarin

2014
Dabigatran use in mechanical heart valve patients.
    Future cardiology, 2014, Volume: 10, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin.
    The American journal of medicine, 2014, Volume: 127, Issue:4

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Warfarin

2014
Dabigatran versus warfarin in patients with mechanical heart valves: comment.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran versus warfarin in patients with mechanical heart valves: reply.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran in patients with mechanical heart valves.
    The New England journal of medicine, 2014, 01-23, Volume: 370, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran in patients with mechanical heart valves.
    The New England journal of medicine, 2014, 01-23, Volume: 370, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran in patients with mechanical heart valves.
    The New England journal of medicine, 2014, 01-23, Volume: 370, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran in patients with mechanical heart valves.
    The New England journal of medicine, 2014, 01-23, Volume: 370, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran in patients with mechanical heart valves.
    The New England journal of medicine, 2014, 01-23, Volume: 370, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Dabigatran in patients with mechanical heart valves.
    The New England journal of medicine, 2014, 01-23, Volume: 370, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Novel anticoagulants in patients with mechanical heart valves.
    Evidence-based medicine, 2014, Volume: 19, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
Comparison of the phase III clinical trial designs of novel oral anticoagulants versus warfarin for the treatment of nonvalvular atrial fibrillation: implications for clinical practice.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014, Volume: 14, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Thiazoles; Thiophenes; Vitamin K; Warfarin

2014
Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
    The American journal of medicine, 2014, Volume: 127, Issue:7

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Substitution; Female; Hemorrhage; Humans; Male; Middle Aged; Warfarin

2014
Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014, Volume: 34, Issue:5

    Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Factors; Brain; Brain Injuries; Cerebral Hemorrhage; Dabigatran; Hemorrhage; Mice; Mice, Inbred C57BL; Warfarin

2014
Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2014, Volume: 40, Issue:1

    Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pulmonary Veins; Retrospective Studies; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin

2014
Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.
    Pharmacotherapy, 2014, Volume: 34, Issue:6

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; United States; United States Food and Drug Administration; Warfarin

2014
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation.
    PharmacoEconomics, 2014, Volume: 32, Issue:6

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Decision Support Techniques; Humans; Markov Chains; Models, Statistical; Morpholines; Norway; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Perioperative management of patients on new oral anticoagulants.
    The British journal of surgery, 2014, Volume: 101, Issue:7

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Clinical Trials as Topic; Dabigatran; Drug Monitoring; Elective Surgical Procedures; Emergencies; Half-Life; Hemorrhage; Humans; Medication Adherence; Morpholines; Preoperative Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Time Factors; Warfarin

2014
A new class of powerful and informative simultaneous confidence intervals.
    Statistics in medicine, 2014, Aug-30, Volume: 33, Issue:19

    Topics: Algorithms; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biostatistics; Confidence Intervals; Dabigatran; Data Interpretation, Statistical; Humans; Models, Statistical; Proportional Hazards Models; Randomized Controlled Trials as Topic; Stroke; Warfarin

2014
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
    Journal of medical economics, 2014, Volume: 17, Issue:8

    Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comparative Effectiveness Research; Cost-Benefit Analysis; Dabigatran; Factor Xa Inhibitors; Female; France; Humans; Male; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy.
    Evidence-based medicine, 2014, Volume: 19, Issue:5

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Venous Thromboembolism; Warfarin

2014
Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.
    The American journal of medicine, 2014, Volume: 127, Issue:11

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Factual; Drug Utilization Review; Factor Xa Inhibitors; Fees, Pharmaceutical; Female; Humans; Income; Male; Middle Aged; Morpholines; Multivariate Analysis; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Sex Factors; Stroke; Thiophenes; United States; Vitamin K; Warfarin; Young Adult

2014
Direct oral anticoagulants in atrial fibrillation.
    Seminars in hematology, 2014, Volume: 51, Issue:2

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Embolism; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin

2014
[Dabigatran versus warfarin in patients with mechanical heart valves].
    Revista clinica espanola, 2014, Volume: 214, Issue:4

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Heart Valve Prosthesis; Humans; Male; Stroke; Thromboembolism; Warfarin

2014
New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?
    Clinical pharmacology and therapeutics, 2014, Volume: 96, Issue:1

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Aryl Hydrocarbon Hydroxylases; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cytochrome P-450 CYP2C9; Dabigatran; Factor Xa Inhibitors; Genotype; Humans; Morpholines; Pharmacogenetics; Polymorphism, Genetic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Vitamin K Epoxide Reductases; Warfarin

2014
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Meta-Analysis as Topic; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Vitamin K; Warfarin

2014
Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin.
    Stroke, 2014, Volume: 45, Issue:8

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hospital Mortality; Humans; Intracranial Hemorrhages; Male; Odds Ratio; Retrospective Studies; Warfarin

2014
Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?
    American journal of hypertension, 2015, Volume: 28, Issue:2

    Topics: Acetylcysteine; Animals; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Pressure; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Nephrectomy; Pyrroles; Quinazolines; Rats; Receptor, PAR-1; Renal Insufficiency, Chronic; Vitamin K; Warfarin

2015
Atrial fibrillation choices. Picking an anti-clotting drug.
    Mayo Clinic health letter (English ed.), 2014, Volume: 32, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Food-Drug Interactions; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.
    BMC health services research, 2014, Jul-17, Volume: 14

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Female; Humans; Insurance Claim Review; Male; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies; Risk; Stroke; United States; Warfarin

2014
Treatment of atrial fibrillation.
    The Medical letter on drugs and therapeutics, 2014, Jul-07, Volume: 56, Issue:1446

    Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2014
Dabigatran, bleeding, and the regulators.
    BMJ (Clinical research ed.), 2014, Jul-23, Volume: 349

    Topics: Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Approval; Drug Monitoring; Europe; Hemorrhage; Humans; Product Surveillance, Postmarketing; United States; United States Food and Drug Administration; Warfarin

2014
Haemostasis. Part 2: Medications that affect haemostasis.
    Dental update, 2014, Volume: 41, Issue:5

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Fibrinolytic Agents; Hematologic Agents; Hemostasis, Surgical; Heparin; Humans; International Normalized Ratio; Oral Hemorrhage; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Warfarin

2014
Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
    The American journal of medicine, 2014, Volume: 127, Issue:12

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Substitution; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; International Normalized Ratio; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Stroke; United States; United States Department of Veterans Affairs; Warfarin

2014
Anticlotting therapy for atrial fibrillation: should you stay with the devil you know? Preventing stroke with warfarin (Coumadin) can be tricky. New anticlotting drugs can help if you accept certain trade-offs--and take them exactly as directed.
    Harvard men's health watch, 2014, Volume: 18, Issue:9

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Female; Fibrinolytic Agents; Humans; Male; Morpholines; Patient Education as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; United States; United States Food and Drug Administration; Warfarin

2014
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:10

    Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Combined Modality Therapy; Dabigatran; Female; Heparin; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Radio Waves; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin

2014
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin

2014
ACP Journal Club. In atrial fibrillation, dabigatran had similar efficacy to warfarin but caused less bleeding in higher GFR.
    Annals of internal medicine, 2014, Aug-19, Volume: 161, Issue:4

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Kidney; Male; Warfarin

2014
Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population.
    Journal of medical economics, 2014, Volume: 17, Issue:11

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Health Expenditures; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
    Stroke, 2014, Volume: 45, Issue:10

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Research Design; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin

2014
Letter by Seitz and Beurtheret regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing risk analysis from the randomized evaluation of long-term anticoagulant therapy study".
    Circulation, 2014, Aug-26, Volume: 130, Issue:9

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Warfarin

2014
Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study".
    Circulation, 2014, Aug-26, Volume: 130, Issue:9

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Warfarin

2014
Anticoagulant-related gastrointestinal bleeding--could this facilitate early detection of benign or malignant gastrointestinal lesions?
    Annals of medicine, 2014, Volume: 46, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Early Detection of Cancer; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Morpholines; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thiophenes; Warfarin

2014
[Cost-effectiveness of apixaban compared to other new oral anticoagulants in patients with non-valvular atrial fibrillation].
    Kardiologiia, 2014, Volume: 54, Issue:7

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Cost-Benefit Analysis; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Models, Statistical; Morpholines; Myocardial Infarction; Prognosis; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Russia; Stroke; Thiophenes; Warfarin

2014
Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    The American journal of medicine, 2014, Volume: 127, Issue:12

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Denmark; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Proportional Hazards Models; Registries; Secondary Prevention; Stroke; Treatment Outcome; Warfarin

2014
Letter by Hifumi et al regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".
    Circulation, 2014, Sep-02, Volume: 130, Issue:10

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Venous Thromboembolism; Warfarin

2014
Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".
    Circulation, 2014, Sep-02, Volume: 130, Issue:10

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Venous Thromboembolism; Warfarin

2014
Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation.
    Journal of the American Heart Association, 2014, Sep-16, Volume: 3, Issue:5

    Topics: Aged; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiac Surgical Procedures; Comparative Effectiveness Research; Computer Simulation; Cost-Benefit Analysis; Dabigatran; Decision Support Techniques; Drug Costs; Equipment Design; Female; Health Care Costs; Humans; Male; Markov Chains; Models, Economic; Models, Statistical; Probability; Quality-Adjusted Life Years; Stroke; Treatment Outcome; Uncertainty; Warfarin

2014
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2015, Volume: 17, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Denmark; Female; Heart Failure; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Myocardial Ischemia; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Registries; Renal Insufficiency, Chronic; Rivaroxaban; Sex Factors; Stroke; Thiophenes; Warfarin

2015
Additional events in the RE-LY trial.
    The New England journal of medicine, 2014, Oct-09, Volume: 371, Issue:15

    Topics: Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin

2014
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding.
    British journal of haematology, 2015, Volume: 168, Issue:6

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Case-Control Studies; Cerebral Hemorrhage; Dabigatran; Humans; Thromboplastin; Warfarin

2015
Activated protein C resistance testing for factor V Leiden.
    American journal of hematology, 2014, Volume: 89, Issue:12

    Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin

2014
Myocardial ischemic events in 'real world' patients treated with dabigatran.
    The American journal of medicine, 2014, Volume: 127, Issue:10

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Myocardial Ischemia; Warfarin

2014
The reply.
    The American journal of medicine, 2014, Volume: 127, Issue:10

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Male; Myocardial Ischemia; Warfarin

2014
Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation.
    Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Cost-Benefit Analysis; Dabigatran; Humans; Morpholines; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014, Volume: 14, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Coumarins; Dabigatran; Humans; Markov Chains; Middle Aged; Morpholines; Netherlands; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiophenes; United Kingdom

2014
Novel anticoagulants eliminate the need for left atrial appendage exclusion devices.
    Circulation, 2014, Oct-21, Volume: 130, Issue:17

    Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Septal Occluder Device; Stroke; Thiazoles; Thiophenes; Unnecessary Procedures; Warfarin

2014
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial.
    BMC family practice, 2014, Oct-25, Volume: 15

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism

2014
Help prevent Afib-related stroke. New anticoagulants for atrial fibrillation prove as effective, or even better than, warfarin--and easier to use.
    DukeMedicine healthnews, 2014, Volume: 20, Issue:9

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Evaluation; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin

2014
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Circulation, 2015, Jan-13, Volume: 131, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Dose-Response Relationship, Drug; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Kidney Diseases; Medicare; Proportional Hazards Models; Retrospective Studies; Risk; Socioeconomic Factors; Stroke; Treatment Outcome; United States; Warfarin

2015
The importance of postapproval data for dabigatran.
    JAMA internal medicine, 2015, Volume: 175, Issue:1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Warfarin

2015
Risk of bleeding with dabigatran in atrial fibrillation.
    JAMA internal medicine, 2015, Volume: 175, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Incidence; Male; Medicare; Middle Aged; Retrospective Studies; Risk; United States; Warfarin

2015
A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2014, Volume: 41, Issue:3

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Cryosurgery; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Morpholines; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2014
Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
    Stroke, 2015, Volume: 46, Issue:1

    Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin

2015
Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Stroke, 2015, Volume: 46, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; China; Cohort Studies; Dabigatran; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Time Factors; Warfarin

2015
Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analy
    Circulation, 2014, Nov-25, Volume: 130, Issue:22

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Kidney; Male; Warfarin

2014
Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysi
    Circulation, 2014, Nov-25, Volume: 130, Issue:22

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Kidney; Male; Warfarin

2014
Atrial fibrillation: Risk of bleeding with dabigatran versus warfarin particularly high in CKD.
    Nature reviews. Nephrology, 2015, Volume: 11, Issue:1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Transition from apixaban to warfarin--addressing excess stroke, systemic embolism, and major bleeding.
    American heart journal, 2015, Volume: 169, Issue:1

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Vitamin K; Warfarin

2015
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment

2015
Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:3

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin

2015
[Advantages and disadvantages of warfarin and pradaxa therapy for venous thromboembolism].
    Vestnik khirurgii imeni I. I. Grekova, 2014, Volume: 173, Issue:4

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Monitoring; Drug Substitution; Female; Hemorrhage; Heparin; Humans; Lower Extremity; Male; Middle Aged; Severity of Illness Index; Tomography, Spiral Computed; Treatment Outcome; Ultrasonography, Doppler, Duplex; Venous Thromboembolism; Warfarin

2014
Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Circulation, 2015, Mar-17, Volume: 131, Issue:11

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Factual; Dose-Response Relationship, Drug; Drug Utilization; Female; Hemorrhage; Hospitalization; Humans; Kidney; Kidney Failure, Chronic; Male; Matched-Pair Analysis; Middle Aged; Morpholines; Poisson Distribution; Practice Patterns, Physicians'; Renal Dialysis; Retrospective Studies; Risk; Rivaroxaban; Stroke; Thiophenes; Warfarin

2015
Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants.
    Nature reviews. Gastroenterology & hepatology, 2015, Volume: 12, Issue:3

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
[Fewer strokes, lower mortality. Large general practice studies confirm good safety profile of dabigatran].
    MMW Fortschritte der Medizin, 2014, Dec-15, Volume: 156, Issue:21-22

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Randomized Controlled Trials as Topic; Stroke; Survival Analysis; Warfarin

2014
Case images: warfarin-induced skin necrosis: a 'novel' solution to an old problem.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2014, Volume: 42, Issue:8

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Humans; Ischemic Attack, Transient; Male; Middle Aged; Necrosis; Skin; Skin Diseases; Thrombosis; Warfarin

2014
[Dabigatran and risk of bleeding].
    Praxis, 2015, Jan-28, Volume: 104, Issue:3

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Novel anticoagulants make life easier for patients with atrial fibrillation. The new drugs have many advantages over Coumadin--but they aren't perfect--and they have no antidotes in case of overdose.
    DukeMedicine healthnews, 2014, Volume: 20, Issue:1

    Topics: Anticoagulants; Antidotes; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2014
Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Stroke, 2015, Volume: 46, Issue:3

    Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin

2015
Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Stroke, 2015, Volume: 46, Issue:3

    Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin

2015
The management of dental patients taking new generation oral anticoagulants.
    Primary dental journal, 2014, Volume: 3, Issue:4

    Topics: Anesthetics, Local; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Dental Care for Chronically Ill; Drug Interactions; Factor Xa Inhibitors; Hemostatic Techniques; Humans; Morpholines; Oral Surgical Procedures; Postoperative Hemorrhage; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin

2014
Patterns of oral anticoagulants use in atrial fibrillation.
    Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2015, Volume: 22, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cross-Sectional Studies; Dabigatran; Drug Substitution; Drug Utilization Review; Female; Hospitals, University; Humans; Male; Practice Patterns, Physicians'; Quebec; Retrospective Studies; Stroke; Time Factors; Treatment Outcome; Warfarin

2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit).
    The American journal of cardiology, 2015, Mar-01, Volume: 115, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Canada; Dabigatran; Hemorrhage; Humans; Male; Medical Audit; Morpholines; Predictive Value of Tests; Primary Health Care; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Warfarin

2015
[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
    MMW Fortschritte der Medizin, 2015, Jan-19, Volume: 157, Issue:1

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Drug Substitution; Half-Life; Hemorrhage; Humans; Kidney Function Tests; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Warfarin

2015
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin.
    Evidence-based medicine, 2015, Volume: 20, Issue:3

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Ischemic Attack, Transient; Male; Registries; Stroke; Warfarin

2015
Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
    Annals of neurology, 2015, Volume: 78, Issue:1

    Topics: Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Bleeding Time; Blood Coagulation; Brain; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Hematoma; Mice; Thrombin Time; Warfarin

2015
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    BMJ (Clinical research ed.), 2015, Apr-24, Volume: 350

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Medicaid; Middle Aged; Morpholines; Patient Selection; Practice Patterns, Physicians'; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; United States; Warfarin

2015
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    BMJ (Clinical research ed.), 2015, Apr-24, Volume: 350

    Topics: Administration, Oral; Adult; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Observational Studies as Topic; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; United States; Warfarin

2015
Safety of new oral anticoagulants.
    BMJ (Clinical research ed.), 2015, Apr-24, Volume: 350

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Thiophenes; Warfarin

2015
Anticoagulation therapy: Bleeding no worse with novel agents.
    Nature reviews. Cardiology, 2015, Volume: 12, Issue:7

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Thiophenes; Warfarin

2015
Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:10

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Treatment Outcome; Warfarin

2015
Effective antidotes for new anticoagulants.
    BMJ (Clinical research ed.), 2015, May-26, Volume: 350

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Thiophenes; Warfarin

2015
Meta-analysis should not be subject to selectivity and imbalance.
    BMJ (Clinical research ed.), 2015, Jun-24, Volume: 350

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Thiophenes; Warfarin

2015
One-Year Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation: Placing Real-World Results Into Perspective.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Bleeding in Patients of African Ancestry Using Dabigatran: A Potential Effect of Creatine Kinase.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
The Role of Selection in the Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
A Methodological Appraisal of Recent Real-World Data Publications on Dabigatran.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data.
    JAMA internal medicine, 2015, Volume: 175, Issue:7

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Hemorrhage; Humans; Male; Warfarin

2015
Neither dabigatran nor rivaroxaban were linked to increased GI bleeding compared with warfarin.
    Annals of internal medicine, 2015, Sep-15, Volume: 163, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Thiophenes; Warfarin

2015
Dabigatran (Pradaxa): deep vein thrombosis and pulmonary embolism. Warfarin remains the standard drug.
    Prescrire international, 2015, Volume: 24, Issue:161

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Pulmonary Embolism; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thrombosis; Warfarin

2015
Letter by Lavine Regarding Article, "Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation".
    Circulation, 2015, Oct-06, Volume: 132, Issue:14

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Hemorrhage; Humans; Medicare; Warfarin

2015
Dabigatran in 'real-world' clinical practice for stroke prevention in patients with non-valvular atrial fibrillation.
    Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Stroke; Warfarin

2015
Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ (Clinical research ed.), 2016, 10-03, Volume: 355

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Pyridones; Rivaroxaban; Stroke; Warfarin

2016
Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.
    Journal of cardiology, 2017, Volume: 70, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; beta-Alanine; Dabigatran; Humans; Warfarin

2017
Anticoagulation therapy: Uninterrupted dabigatran during ablation for AF.
    Nature reviews. Cardiology, 2017, Volume: 14, Issue:5

    Topics: Anticoagulants; Atrial Fibrillation; beta-Alanine; Dabigatran; Humans; Warfarin

2017
Osteoporotic Fractures Associated With Dabigatran vs Warfarin.
    JAMA, 2017, 07-04, Volume: 318, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Osteoporotic Fractures; Stroke; Warfarin

2017
Osteoporotic Fractures Associated With Dabigatran vs Warfarin-Reply.
    JAMA, 2017, 07-04, Volume: 318, Issue:1

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Osteoporotic Fractures; Stroke; Warfarin

2017
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    The New England journal of medicine, 2017, 08-03, Volume: 377, Issue:5

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Treatment Outcome; Warfarin

2017
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    The New England journal of medicine, 2017, 08-03, Volume: 377, Issue:5

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Treatment Outcome; Warfarin

2017
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    The New England journal of medicine, 2017, 08-03, Volume: 377, Issue:5

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Humans; Treatment Outcome; Warfarin

2017
Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation?
    International journal of cardiology, 2018, 11-15, Volume: 271

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; beta-Alanine; Dabigatran; Humans; Stroke; Warfarin

2018
Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India.
    Value in health regional issues, 2022, Volume: 31

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Humans; Stroke; Warfarin

2022